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INTRODUCTION 
fw;wYQhdf; fUj;jwpe;Njhu;fs; fkygjk; 
ngw;wYQ;rpj;jpg; Ngupd;gf; fy;tp gpwthj Kj;jp 
itj;jhYk; ntw;wp kUtpatu;gjk; tzq;fTk; ahd; 
rpj;jhjp rpj;ju; gjpndz;ku; je;j jputpaNk. 
        %ypif ku;kk; - fz;Zrhkp gps;is g - 1    
                    
Evergrace has its own natural system of healing and Tamil culture has very long 
history of unbroken tradition of healing system called siddha system of medicine.This 
well codified system of medicine is developed by eternal saints called “Siddhars’’ and 
hence it has the name as siddha system of medicine . 
These spiritual scientist felt that the body is best tool for their spiritual attainment 
and they developed this system of medicine to preserve the same from disease, death 
and decay.Natural products like plants,minerals,metals and zoological products are 
used as medicine.They followed very methodical intricate procedures to prepare these 
medicine to convert  them to bioavailable form. Many refractory and metabolic 
diseases are draft in siddha medicine since oldentime.  
Neerizhivu (Diabetis mellitus) is probably the single most important metabolic 
disease and wildly recognized as one of the leading causes of death and disability.If 
affects everycell in the body and the body’s essential biochemical processes, it is major 
public health problem in developing countries like India. 
    In india alone, the prevalence of diabetes is enpected to increase from 31.7million in 
2000to 79.4 million in 2030.In India, faces of paradox of families, in which the children 
are under weight.The prevalence of type 2 diabetes is 4-6 times higher in the urban areas 
as compared to rural areas.The prevelence of impaired Glucose tolerance (IGT) in the 
rural population is also high at 7-8%. This indicates presence of Genetic basis for Type2 
diabetes in ethnic Indian population. 
     Risk factors for developing type 2 diabetes,peculiar to the Indian population are high 
familial aggregation,central obesity,insulin resistance and life style changes including non 
healthy food habits.Sedantory life style is one of the significant factors associated with 
diabetes in this population.The insidious onset of the disease and long duration of 
asymptomatic disease before the symptoms develop makes the prevalence of 
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complications quite high even at the time of diagnosis of Type2 diabetes like micro 
vascular disease and macrovascular diseases. Micro vascular complications like 
Retinopathy, Neropathy, Nephropathy and Macro vascular complications are 
Atherosclerosis which leads to myocardial infarction and stroke.Though many drugs are 
used in contemporary medicine.  
The development of complications are also found to be high. The limitation of 
currently available oral antidiabetic agents inferms of efficacy and safely created the 
need for development of indigenous,natural inexpensive drugs are sought after for the 
prevention of disease complication and for better therapeutic effect.In siddha system of 
medicine many herbal drugs are indicated for Neerizhivu.disease 
Serankottai (Semecarpaus anacardium) is one of the acclaimed kayakalpam drug 
mentioned in siddha classical literature extracts or crude drug extract of semicarpus seed 
for its antidiabetes effect.(semalty 2010, Jaya aseervatham 2010) 
Usually in siddha system, Serankottai is used as Ghee, legium which are called as 
serankottai nei or mahawalladi legium.In siddha literature, yakobu vaidhya cinthamani 
700 authored by Ramadevar clearly states medicated for various degenerative diseases 
including Neerizhivu. Many scientific studies done for these drugs for its anti-
inflammatory, antioxidant coupled with immunomodulatory effects make this drug very 
essential as if was termed in siddha classics.The previous studies were also done with  
About the Serankottai Thiravagam which is to be prepared by distillation method. 
Thiravagam is a special type of acid or alkali distillate prepared with herbal or 
herbominerall salts.Thes preparations are generally indicated in chronic,degenerative 
diseases like Neerizhivu.This theeneer form makes this preparation unique,palatable,and 
easily dispousable one.No scientific study of Serankottai thiravagam is undertaken 
sofar.In the present study Serankottai thiravagam is prepared as per Yakobu vaidhya 
chinthamani 700 in our lab.This drug was studied for its preclinical, including 
Toxicological studies.Also this drug was studied for clinical efficacy on Neerizhivu noi.             
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AIM AND OBJECTIVE 
      AIM 
In my experience that siddha is natural medicine and also to be considered as the 
people’s medicine for ever.First I selected the disease Neerizhivu (Diabetes mellitus) one 
of the leading disease affected most of the people who are either in rich (or) poor among 
the developed and developing countries. So I had decided to select the best medicine 
having no side effect and economically low cost for using of all.When I had referred a 
book as     “Yakobu vaidhya chinthamani 700” written by “Ramadevar”, i selected the 
medicines which is “Serrankottai thiravagam” having the ability to control the type 2 
Diabetes mellitus- Madhumegam as described in siddha literature. 
 
OBJECTIVE 
1. To make a detailed study on the course of the disease, etiology, pathogenesis, 
treatment and prognosis by making use of siddha concepts based on literature. 
2. To study Madhumegam in various literature in comparison with modern science. 
3. To carry out a clinical trial with two compound formulations. 
4. To understand the incidence of the disease with referece the age, sex, thainaigal, 
paruvakalam, socio economic conditions, diet and family history. 
5. To explore the utilize,the diagnostic methods envagai thervu,mentioned by 
siddhars to know about the manifestation of the disease due to disproportionate 
mukkutram,udal thathukkal with specific reference to Naadi,Meerkuri,Neikuri. 
6. To use siddha and modern parameters to confirm diagnosis severity and progress 
of the disease. 
7. To evaluate the biochemical and Microbiological features of the drug. 
8. To undertake pharmacological and toxicological study of the drug. 
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REVIEW OF LITERATURE 
SIDDHA ASPECT 
           The siddha system is originated by LORD SHIVA’’.Agasthiyar is the first disciple 
of shiva.nobody deny the fact that Agasthiyar was Guru and pioneer.propagate this siddha 
system of medicine. 
       In siddha system of medicine the NEER NOIKAL has been classified broadly into 
two categories. 
    1. Neerinai perukkum Noi (Adhi moothiram-Exceesive Urination) 
   2. Neer Arukkal Noi (Neer kattu-Neer Adangal-Retention of Urine) 
 
The same has been described in siddha literature as follows: 
நீரிருவினைக் குணத்னை நீயறிவிரித்துச் ச ொல்வவொம் 
நீரினை செருக்கச ொன்று நீரினை யருக்க ச ொன்று 
நீரிழிவுடவை சகொல்லும் நீர்க்கட்டு வினைகசென்று 
நீணி  முனைக்கும் மிந்ை நீர்நினறக் குணத்னைக் வகெொய்  
நீரினைப் செருக்க ச ன்னும் நீரிழிவி க்கணங்வகள்  
நீ  வொரிைி வெொற்குக்கி நீட்டிக்கு முனை ைள்ெொடும் 
நீவி கூடொது னககொல் நீ மொவினை வநைொடும் 
நீஞ் ச ொணொவுைைின் மூச்சு நீ மொமுயக்கள் கொட்டும்.    
       
Neerizhivu has been described and classified under the Neerinai perukkal Noi’. 
The Ayurvedic and Unani system of medicine have entertained similar views 
about this disease and postulated paralld views about this origin and management of this 
disease. 
The Indian outstanding physicians Charaka as early as 300B.C was the first to 
give Information to the world about the sweet taste in urine   Charaka samhita. 
 
VERUPEYAR-SYNONYMS 
 Neerizhivu-Excess of urination (T.V.SAMBASIVAM PILLAI Dictionary) 
Ennipu Neer - The urine is sweet in taste (Noi Naadal) 
Vegu moothiram. 
Madhu prameham. 
Madhumegam. 
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Thithippu neer.  
Migu neer.  
DEFINITION (IYAL) 
Neerizhivu is defined as large quantity and high frequency of 
urination.Derangement of the seven udal thathukkal and loss of weight.    
Noi nadal   Part - 1                                                                
Urine of the Neerizhivu patients attracts flies and ants in large numbers.when 
heated it gives a sweet aroma.                      
Ïå¥ghd Ïå¥gšy  < tªjjhL« 
xUJëthŒ é£lh®if¥ ÃâahŒ njh‹W«” 
                                     FUeho nehŒehlš ghf«   - 135 
                                                                                
 “Úçid¥ bgU¡fby‹W Úçê éy¡fz§nfŸ 
   ÚythçÂ ngh‰ F¡» Ú£o¡F Kiu jŸshF« 
  Úé TlhJ if, fhš Úykh éid neuhF« 
  ÚŸ brhdhÎuå‹ _¢R Úrkh Ka§f¡fh£L«” 
njiua®  kfh fçrš g-135 
 
Abdomen distends like sea, slurring of speech peripheral neuritis, lassitude, 
dyspnoea are the symptoms of Neerizhivu.  
             
               “m©ikahao¡ fo¡F Úçw§F 
 ko¡fo¡F miuehê jåny fhQ« 
 bt©ikahd joa jå‰wh‹ Ão¡F« 
 ä¡fhd rl« btS¤J nkåf‹W«” 
                                                                    ô» it¤Âa Áªjhkâ g-117 
 These lines quotes frequent micturition, more than the normal with large quantity 
resulting in detoriation of gradual dimnision of sevan udal thathukkal 
As per Athma Rakshmirrtham body becomes weak, weight loss, dryness of skin 
and tongue, excessive  thirst, tiredness, excess sleep indicate the presence of 
megaroham.Athma Rakshamirtham. 
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ntF %j;jpuj;jpd; Fzk; 
md;dNk Nfzp khe;ju; 
 mUe;JeP;u; kpfTk; nghq;fpj; 
jd;Ds;Ns Rtwh tz;zk; 
 jq;fpNa kpFjpahfp 
,e;epwkpy;yh ehS 
kpiltplh jpwq;F khapd; 
     tpd;dKk; nra;Ak; nta;a 
 ntF %j;jpuj;jpd; thNw 
In spite of excessive intake of water for quenching the thirst, it is continuosly 
excreted like a spring in the well. 
 
Epidemiology 
A detailed study on the basis of geographical variation is also considered to be one 
of the important causes for Neerizhivu or Madhumegam. 
 
KURINCHI  
Mountain and their adjoining areas. In India, most of the pancreatic diabetes cases 
have been reported from the midland and the hilly tracts of the southern districts of 
Kerala and Tamil Nadu. 
 
MULLAI 
Forest and their adjoining areas.  
 
MARUTHAM 
Fertile agriculture land and their adjoining areas near river bed are always healthy. 
 NEITHAL 
Sea and their adjoining areas. 
 
PALAI 
Desert and their adjoining areas because of the proverty,they suffer from ill health. 
Recent research indicates that the poor were also prone to diabetes. Research was             
being conducted to analyse whether rapid changes in their lifestyle or the stress of 
proverty triggered diabetes.   
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NOI VARUM VAZHI-AETIOLOGY 
 
“nkfbkD ÚuêÎ tU« éj¤ij 
és«ò»nw‹ K‹brŒj f®kªj‹dhš 
jhfKl‹ kJgjh®¤j§fŸ e‹whŒ¤ 
jh‹òÁ¤j yhYŠÁ‰¿d¤Â‹ k§if 
nghfkÂ fç¤jyh Y£odªjh‹ 
nghjnt äŠRjyhš jæ®nkh® beŒghš 
VfkhŒ¥ òÁ¤jyh‰ bfhG¤j ñid 
ba‹W K©z Yt®Úiu¡ Fo¤jyhny 
MirÍl‹ ÁWtGjy§fhŒ j‹id 
aÂfkh Í©gjhš fhyªj¥Ãš 
nghrd§fŸ  brŒjyhš eilaiy¢rš 
nghjnt æU¤jèuh f©éê¤jš 
njrbk§F Âçjyh äitfshny 
Áuªjå‰N lÂf§ bfh©Llnd u¤j« 
nrhînj aÂfkhŒ nkfªnjh‹¿¤ 
bjhšiy brŒÍ« ÚuêÎ« ÏUgjhnk. 
 
                                                   rungªÂu nkf ãthuz nghÂå 
                                                      v‹D« ÚçêÎ nehŒ kU¤Jt«. g¡f« - 1 
Sexual Indulgence:                 
  “f‹å ka¡f¤jhš f©oL nkfnk 
ÂU_y®  Á¤j kU¤Jt« g- 485 
  “epiw g+j;j nfhq;ifahs; ehafd; Nkhfj;jhy; 
kiw Nghw;Wk; fUg;gj;jpy; tsHe;jJ NkfNk”  
;                      jpU%yH rpj;j kUj;Jtk; g - 485 
 “»uªÂ¥ ò©âuz  nkf¡ 
Ñrf bd‹Dª J‹ kh®¡f‹ 
mUªjÂ ba‹D« ghŠrhè  a‹idia¡f©Q‰whnd” 
  kU¤Jt ghuj« - Á¤j kU¤Jt« g-485  
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According to Thirumoolar and Therayar, excessive indulgence in sex causes megaroham. 
];jphp Nghfk; nra;jjpdhy; NtTnfhz;L 
rpuR kl;Lk; nte;JUfpf; fdNy kPwpf; 
FwpAlNd Nkfe;jhd; nfhLik nra;J  
Fiwe;J tUk; jhJnty;yhk; Fd;wpg;NghFk; 
FUehb nehŒ ehly ; g - 250       
Diet Habits 
nfhija® fyé nghij  bfhG¤jÛ åiw¢Á nghij                                                                   
ghJthŒ beŒÍ« ghY«   gçÎl  D©Õ uh»š 
nrhjgh© LUt ä¡f   R¡»y Ãunkfªjh‹ 
xJ ÚçêÎ nru t©bld t¿ªJ bfhŸs 
 (mf¤Âa® 1200) Á¤j kU¤Jt«  g- 470 
 “c‰gé¡F« ghš beŒah èiw¢Á fŸshš 
cçirahŒ  Û‹w‹dhš  tUéU¤j 
k‰gé¡F« gjh®¤j¤  jhš kJu t°jhš 
kªj§fŸ jå‰ bghÁ¤jš ntfh¥  g©l« 
F‰gé¡F§ Fëªj t‹d k§if nfhZo 
F¿¤j ã¤ Âiujé®j y¡»å kªj«” 
ô» it¤Âa Áªjhkâ -  g- 146 
Excessive intake of  food  rich in carbohydrate and fat, red meat, sweet food, raw 
food and sleeplessness give raise to Neerizhivu quotes Agathiyar and Yogi Munivar. 
 
Psychosomatic Cause: 
 “Ïa«gnt MWFs« Ã‹dŠ brŒjš 
V‰wkhŒ Ãuhkz°Âß r§f« g©zš 
ga«gnt ghy®fS¡ bfhë¤J¤ Â‹dš 
gHit ry« nghw têjid¤ jL¤jš 
ma«gnt Nya¤Â‰ ry«é£l nlh®¡F« 
MÂah« ntj¤ij  ¤öî‰  njh®¡F« 
Ja«gnt Nçaid tz§  fhjh®¡F« 
RU¡fh nkf« tªJ‰g  é¡Fªjhnd” 
ô» it¤Âa Áªjhkâ – 144  
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According to Yogi Vaidya Chinthamani, Megaroham may occur due to not giving proper 
respect to Guru, Father, Mother, Vedas and suriyan god. 
 
jhsh NkfQ; rhWk; tif jd;idf; NfspH kyf;fl;lhw; 
Nfshr; rj;jhy;;; fhzhf;fz; Nfl;Lf; fz;Lk; Nghw; Ngrpf; 
Nfhof; fUj;jpw; wha; je;ij FUitg; gopf;Fe; Njh\j;jhy; 
Thohf; fd;dpf; fw;gopj;J tuk;G jtwpy; tUnkd;Nw 
jd;te;jphp itj;jpak g - 75;. 
 Obesity: 
  “j‰Ãé¡FŠ rßuªjh‹ äf¥g U¡fš 
   ršryªjh‹ ga‹gLjš  jç¡F« nehna” 
ô» it¤Âa Áªjhkâ  g- 146 
 Obesity is one of the main causes of Neerizhivu or Madhu megam. 
 
Deeds: 
“jhnd  óUt éÂædhš rhU« Ãâf bsšyh« 
 khnd® éêahŸ nt£ifædhš tUªJ« Ã‹D« gÁahš 
jhnd bghW¤J c©ifædhš jhfªj‹dhš äf¢nrh®ªJ 
 jhnd fky« ò©zh» brŒÍ« Ãunkf¢ brašjhnd.” 
Njiuau; kUj;Jtghujk; g -25 
Mkg;gh kdpjH nra;j fUkj;jhNy 
 Mufuh Nkf nkd;w uhrhthNy 
fhkg;gh yjpdhy; grpag;gh ehYk; 
iff;flq;f Neha;fs; tUk; fHkj;jhNy 
mfj;jpaHfd;k fhz;lk g-88 
 
From the above poems, the diseases also occur as a result of bad deeds committed 
in previous or these births. So yogi, Therayar, Agathiyar, Thirumoolar andothers says that 
theNeerizhivu (madhumegam) comes by karmavinaigal and bad deed also. 
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Hereditary: 
“Kiwnf£»š x‹gJ Ka‰Áahš tªjJ 
Jiw nf£»w fU¥g¤Â‰ Wt§»a nkf§fŸ 
ãiw ó¤j bfh§ifahŸ ehaf‹ nkhf¤jhš 
kiw ngh‰W§ fU¥g¤Âš ts®ªjJ nkfnk” 
                                                              -  ÂU_y® g - 110. 
“R¡»y¤Âš Rnuhâ j§fŸ fy§Fbk‹W 
 ó§»L«  éahÂ _‹W«” 
       (j‹tªÂç eho) nehŒ ehly; g 
“jhNd GUt tpjpajdhw; rhUk; 
gpzpf sy;yhky”;   
Njiuah; thflk; g - 116 
 
Thirumoolar and Dhanvantri have noted in their literatures that Hereditary is one 
among the causes of the disease Neerizhivu.present day researchers have found out that 
genetic factors play an important role in Neerizhivu. 
 
Excess Stimulation of Moolatharam: 
 
rçahd nkf¤jh yghd thÍ 
jh‹ òif¡F nkny¿¡ fghy¢ Nlh« 
bgçjhd nkf¤jh y¤Â btªJ 
nghk¥gh jirbtªJ u¤j« t‰¿¥ 
gçth»¤ jr thŒthš kªj§ bfh©L 
bgUªÔå  kygªj« cjhd thÍ  
éçth»¤ njfbkšyh« él % uhny 
bkŒaêªj njfbk‹w ÂUgjh¢nr”   
 nehŒehlš ghf«  1  g- 420 
Among the six Atharams the Moolatharam is situated in between recturn and 
genitals, just end of sacral plexus. 
            In the Neerizhivu disease, impaired Abana vayu (excretory junction) inactivate 
the moola agini during that time excess intake of food causes inactivation of dhasavayu 
11 
 
which create excessive appetite (Polyphagia) and constipation.  Udanan is also affected.  
These changes in turn cause the derangement of seven udal thathukal. 
 
Nkf Neha; cz;lhtjw;F VJ: 
“khju; kaf;f kpFjpadhd; kjpap  yr;r kpFjypdhhy; 
Nghij jUq;fs; sUe;Jjyhw; Gyhd; kPdpiwr;rp nea;ghyhy; 
rPjTzthw; gjdope;j jpiz tpUk;gpj;jpd; gjdhy; 
XJ Kztpd; NkYzthYlk;G gUj;jypdhy; 
 
mUe;J Kztp ypdpg;gjpf khf Twyh y;uhf;fhyk;  
nghUe;J Kwf;fe; jtpu;jypdhhw; grpg;Gf; Fiwthd; kpFjpapdhy; 
jpUe;J klthu; Nghfkw tplyhd; kpfyhw; Nwfkpf  
tUe;j ntapypd; kpFeilahy te;JNjhd;Wk; gyNkfk;.” 
guuhr Nrfuk g - 3;. 
MURKURIGUNAM  (PREMONITORY SYMPTOMS): 
 
jhfNk ajpf khfpj; jsh;e;J eh cyh;e;jkpf;f 
Nrhfkha;f; fpWfpWj;Jj; njhlh;e;Jif fhYk; Nrhh;e;J 
Vfkha;g; gfY ky;Yk; tplhJ ePhpwq;Fk; md;wp 
Nkhfkha; kio gdpf;F Kjph;e;jpwq; fpLQ;rye;jhNd 
                      .               itj;jpa tpsf;fk; g - 49    
Premonitory symptoms of Neerizhivu are poly uria, poly phagia, poly dipsia.  
Neerizhivu exhibits the following premonitory symptoms from its initial stage of 
development itself.  The patient experiences voracious hunger, thirst, perspiration, 
exhaustion and giddiness.  The excessive intake of water to quench his thirst is excreted 
as excessive quantity of urine (poly uria).  In spite of abnormal consumption of food, 
stamina continues to decrease. 
Noi Nadal Part I P .NO.  256 
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kJnkf« bghJ F¿Fz« : 
 
Twhd nkfkJ ÏUgJ¡F« 
Fzªj‹id¢ Át‹brhšy njé nf£f 
jhwhd jhfbkhL nrhfnkfª 
jçahkš Úçêj  éUkš _¢R 
Mwhd mUÁr¤Â Á¤j¥  u«ik 
mofo¡fo¡F¤ j©Ù®jh‹ m§nf nf£fš 
<whd ÏL¥ò¡FŸ fL¥ò fhzš 
vY«òH‰w yH‰wy blçÎ lhnk 
vçnthL rßubkšyh kiwg£lh‰nghš 
vY«ò nehjš ã¤Âiuæš yhikh 
  
tçnthL khŒébk¤ jÎ«g¿¤jš 
kdJrŠ  ry¥gLjš  fh‰W nt©lš 
bkçnthL nkš _¢R äfÎ©lhjš 
é¡fbyhL ka¡fªjh‹ bk¤j¡ fhzš 
bjçnthL njfbk§F« btSU©lhjš 
njfbk¤j thnyhg¥ gLjš fhnz” 
ô» it¤Âa Áªjhkâ  g- 155 
 
Common Symptoms: 
 
Thirst    Polyuria 
Poly dipsia   Cough 
Anorexia   Dyspnoea 
Delirium   Pain in the hip and burning sensation 
Sleeplessness   loss of weight 
Hiccough   Flatulance 
Anaemia   Giddiness 
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NOI VAGAIKAL- (CLASSIFICATION) 
 
Megarogam is classified into twenty varieties to quote from Agasthiar 
 
 “c£oz nuhf¤jhY« cW«bgU« gÁædhY§ 
f£léœ  nfhij khj® fyék£oyh ikayhY 
K£lwh ehYkhW K« _‹W bkh‹W bkh‹W 
Â£lkhŒ tUtbj‹W ÂUKå aUë¢ brŒjh®” 
     mf¤Âa® Á¤j kU¤Jt« -  g-471. 
Yugi Munivar classifies the same as 
 
trå¤j nkfkJ æu©L g¤J 
thj¤Â‰ Ãwªjry« ehnyahF« 
Ãrå¤j Ã¤j¤ÂY  ‰wgé¤j 
nguhir yªjhD khW khF« 
njråªj nr£Lk¤ÂY‰g é¤j 
Óuhd ryªjhD« g¤njahF«. 
ô» it¤Âa Áªjhkâ  g-145. 
According to Theraiyar 
“fêÍ« thj« eh‹fhY«  fhÍ« Ã¤j khwhY« 
RêÍ« nr¤Jk« g¤jhY« brhšY« ehyŠrhŒ njh‹W«” 
        njiua® thfl«  g-42 
NOI VAGAIGAL 
 
Ehy;fs; Neha; vz; tsp moy; Iak; 
mf¤Âa® 1200 20 4 6 10 
ô» it¤Âa Áªjhkâ 20 4 6 10 
njiua® thfl« 20 4 6 10 
j‹tªÂç it¤Âa« 20 4 6 10 
rungªÂu ÚçêÎ nuhf Á»¢ir 20 4 6 10 
ô» Kå it¤Âafhéa« 20 4 6 10 
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The above books describe twenty different kinds of megam (urinary   disorders) 
on the basis of colour, consistency, taste, smell, weight etc. 
Out of this twenty different kinds 
Four varieties are caused by vali 
Six varieties are caused by Azhal 
Ten varieties are caused by Iyam 
Neerizhivu comes under the classification of Azhal. 
 
Classification of Megam: 
                      According to Yugi Vaidhya Chinthamani 
 
thjÚ® tiffŸ  
  “jç¤Â£l thj¤Â‹ ryªjh dhY 
jåahd ehY¡F« ngnu bj‹åš 
mç¤Â£l M¢ÁabfªÂ nkf¤njhL 
mj‹ÃwF R‰wkh  nkfbk‹W 
Ãç¤Â£l Ãuäa nkfbkh‹W 
nguhd kh§fué nkfbk‹W 
ô» it¤Âa Áªjhkâ g-146. 
 
Vali – 4 
1. Neimananeer (Mr;rpafe;jp Nkfk;) 
2. Pasumana neer   (Rj;j Nkfk;) 
3. Seezhmana neer (thjgpukpa Nkfk;) 
4. Sathaimana neer (khq;fprrpuhtp Nkfk;) 
 
Ã¤j Ú® tiffŸ 
Kiwahd Ã¤j ry khWkhF« 
KÂ®ªj m¥Ãa bk‹W« Ãuäa bk‹W« 
Jiwahd rh«Õ®zkJ«g bk‹W« 
rh¤Âfnk ahWéjª  j‹ndh lhW” 
ô» it¤Âa Áªjhkâ – g- 148 
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Azhal – 6 
1. Yanai kozhupu mana neer  (mg;gpa Nkfk); 
2. Katrazhai mana neer (gpj;jgpukpa Nkfk;); 
3. Chunna mana neer (rt;tpuz Nkfk;) 
4. Innipu megam (kJNkfk;) 
5. Palingu neer (rhe;jpu Nkfk); 
6. Muyal kurithi neer (Mu;f;f Nkfk;) 
IaÚ® tiffŸ 
 “Mwhd Ány£gry« g¤J j‹id 
mu‹ brhšy M¤jhŸ jh‹ nf£F« nghJ 
thwhd trhnkf« c¤rnkf« 
k¢Áahnk  f¤njhgh Ñj nkf« 
öwhd Ruhç R¡y K¤j nkf« 
R‰wkh«Ã  dhåbahl  tyz nkf« 
nfwhd  bjÍ¤jakh nkf bk‹W 
br¥Ãdh® Ány£ g¤Â‹ brY¤J¤ jhnd” 
ô» it¤Âa Áªjhkâ  g- 151 
Iyam – 10 
1. Iaya Neer (trh Nkfk;) 
2. Thuimai Neer ( cj;jk Nkfk); 
3. Moolai neer (kr;ir Nkfk); 
4. Ilaneer (Mjpf;f Nkfk); 
5. Kal neer (Ruh Nkfk;) 
6. Thavala Neer (Rf;fpy Nkfk); 
7. Kazhu neer  (cjf Nkfk); 
8. Then neer (gpur Nkfk); 
9. Uppu neer (rhu Nkfk;) 
10. Avichi Neer (ijj;jpa Nkfk;) 
Yugi described four types under the Vatha premeham, six types under the pitha 
prameham and ten types of under Kaba prameham. “Diabetes mellitus” a clinical entity 
in a modern medicine is closely resembles one of the type of pitha prameham ie 
“Neerizhivu”. 
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guuhr Nrfuk; Ehypy; $wg;gl;Ls;s ePupoptpd; tiffs;;: 
rpNyw;gd Nkfk;-10 
rpf;fha; Nkfk: 
“kpf;f Nrw;gdj; njOe;j NkfePu; gj;Jq; Nfsha; 
rpf;fhaq; fyq;f dPuha;r; rpWnfz;ilr;rpd;d Nghw;Nwhd;wp  
xf;fNt Jtu;gha; Kw;wp Aly; fiue; jpwq;Fk thdPu; 
tpf;fy; nfhl;lhtp Jk;kd; kpFe;jpLq; Fzq;fshNk”  
     guuhr Nrfuk; g – 20 
Urine is turbid and astrigngent. 
Emaciation sets in. 
There will be increase in hiccough, sneezing and yawning possibility of respiratory 
disorders. 
Gyhy; Nkfk: 
“Nfl;blha; Gyhd;Nk fe;jhd; nfk;GkPd; fOT ePu;Nghy; 
Kl;ba tdyha;r; Rl;L %f;FePupwf;f khFk; 
Nfhl;bfs; gyT Kz;lhq;Fwpab NehFk; Gz;Nghy; 
ehl;bdp ypjd; Fzj;ij etpd;wdu; nghpNahh;; jhNk”; 
     guuhr Nrfuk; g - 21 
Urine resembles fish washed water. 
Body temperature increase with rhinitis.Burning micturation with pain in the genitalia. 
,ytz Nkfk;: 
“tpUk;gpa ytzNkf kpFe;jeP Ug;G iwf;Fk; 
JUk;ngd Nkdp tw;We; njhz;ilAq; fd;wp Nehthk;  
jpUk;gePu; fha;r;rpg; ghh;fpw rpte;JTg; ghfpj; Njhd;Wk; 
FUk;igapd; Kiyed; khNj NfhrK nkupTz;lhNk” 
     guuhr Nrfuk; g – 22 
Urine is salty with reddish tinge. 
Weight loss setsin.  
Soar throat occurs due to infection. 
kJNkfk;: 
“kJNkfQ; nra;F ze;jhd; thaJ fre;J fhl;Lk; 
,jk;tUk; gpd;ndLf;Fk; ahidKk; kjNk Nghy 
KjaeP nuLf;Fk; ghNy Kw;wpa Gspg;G ehLk; 
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mjpfkhj; jhfKzlh kah;e;Jly; tyf;F nkd;Nd” 
     guuhr Nrfuk; g – 23 
Bitter taste linger. 
Patient became restless. 
Urine ferments like milk. 
Morbid thrist. 
Extreme tiredness. ; 
Mde;j Nkfk;: 
“jpl;lkh de;j NkfQ; rpWfUk; gpdpw;rh nwLj;J 
tpl;lePu; Fspu;e;J fhl;Lk; Ntjpiz kaf;f Kz;lhk; 
Kl;lNk Yise;J ise;J KJfe;jz; nlYk;G Nehthk; 
ml;lNk jhjp #j;jpu kha;e;jpL nkd;W fhNz” 
     guuhr Nrfuk; g – 24 
Urine resembles sugarance juice and is cold 
Patient is exhausted and complains of lumbar pain 
 kfh Nkfk;;: 
“nrg;gpa kfhNk fe;jhd; rpf;fha; kpwq;F ePupd; 
Jg;ngdj; njupj;J tPOQ; RUf;nfdf; FWf;fpw; Fj;Jk; 
Fg;Gwj; js;spf; fhl;Lq; Fzk;tUk; ntF ePUz;lhk; 
,g;gbf; Fzq;f shnkd; wpak;gpdhh; Kdpth; jhNk.” 
     guuhr Nrfuk; g – 25 
There is obstruction in the urinary flow. 
Intense pain in the lumbar region. 
There is excessive urination in Neerizhivu. 
fhr Nkfk;: 
“,ak;gpa fhr Nkfk; Nkjkha; thapdpf;Fk; 
Tpad;ngw Kfq;f Wf;Fk; ntz;Ziu ePNw tPOk; 
mah;e;J fz; ^f;fKz;lh kbuz;Lq; fhe;jyhFk; 
eae;Jrw; wpUkh Yz;lh eae;jth; etpd;wthNw.” 
     guuhr Nrfuk; g – 26 
Sweet taste lingers 
Face turns black. 
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Urine becomes white forthy. 
Patient experiences deep sleep. 
Burning sensation in the sole of foot. 
Presence of cough. 
ntwpNkfk;: 
“ntwpNkfk; gf;f khfp kpfntwp Nghyf; fhl;Lk; 
mwpAkhl; biwr;rpj; jz;zPuh nkd ePupwq;Fk; 
,WfpNa kyk;tp lhjhkpjw;FKw FbePu; jd;dpy; 
newpajh ag;gp Nuf eprkplj; jPUnkd;Nw.”  
    guuhr Nrfuk; g – 27 
Aggressive mental attitude. 
Beef washed water like urine. 
Presence of hard stools. 
 
NOIKURI KUNANGAL – (CLINICAL FEATURES) 
“jz;ikaha;r; rye;jhDk; gRg;G kQ;rs; 
       jhdpwq;Fk; gPrKq;Nfh rKq;f Lf;Fk; 
mz;ikah abf;fbf;F ePup wq;Fk; 
      mbf;fbf;F miuehop jdpNy fhZk;; 
ntz;ikah abjdpw; whd;gp bf;Fk 
      kpf;fhd rlk;ntSj;J Nkdp fd;Wk; 
gz;ikaha;g; gQ;rthz; ljdpw; nfhy;Yk; 
       gfu; fpd;w kJNkfg; ghq;FjhNd” 
     A+fpitj;jpa rpe;jhkzp g – 127 
 Poly urea, Poly phagia, poly dipsia, perspiration, exhaustion, insomnia, giddiness 
and loss of weight even at normal consumption of food. 
 
Common sign and symptoms of Pitha Prameham 
 “m¿ant  Ã¤jry khW¡Fªjh‹ 
  m§fkÂ‰ brŒ»‹w Fz¤ij¡ nfshŒ 
  j¿ant rßu« t‰¿ baçÎ©lhF« 
  rl¤ÂYª ÚçYªjh‹ fé¢R©lhF«. 
  bj¿ant  Ó¥nghY§ f‰whiH nghY« 
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  nrš  nghYª nj‹ nghY« eh‰w K©lh« 
  bt¿ant  Õr¤Â‰ nfhr¤Â‰ Fj¤Âš 
  äFÛuš ehÃæY« nt¡fh lhnk 
  nt¡fhlhŒ éuz K©lhŒ thŒjh‹ ehW« 
  é¡fbyhL mUÁaha¢ RuK©lhF« 
Ô¡fhlhŒ¤ njfªjh‹ »ilbfh£lhJ 
  Âa¡fbkhL  _®¢irÍ©lh ka¡f khF« 
 rh¡fhlhŒ  ehtwª j©Ù® jhf« 
  r¡ÂbahL  rßuahF« 
  jh¡flh kyrŠryªjh‹ äfÎ©lhF« 
  rkFzªjh‹ Ã¤j ry khW kh¢nr 
ô» Áªjhkâ g- 181 
  
As per the above poem, poly uria, poly phagia, Poly dipsia, fever, angular 
stomatitis, pruritis vulvae, balano posthtis, burning sensation all over the body, loss of 
weight, are common signs and symptoms of pitha prameham. 
 
MUKKUTRAIYAL: 
 “thjkha; gilj;J,gpj;j mdyha; fhj;J 
  Nrj;k rPjkha; Jilj;J” 
 Njiuau; kUj;Jtghujk; g- 81 
Vali: 
Sites of vali: 
BelowNaval, Urinarybladder, intestines, pelvis, umbilicalcord thigh, bone, skin, 
Nerve endings, joints, musculature and hair root. 
Properties: Dryness, lightness, clearness, coolness, mobile formless. 
 
Functions:  
 Stimulation, respiration, thinking sensory function, coordination of seven physical 
constituents, reflex action. 
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In Neerizhivu: 
 
Piranan  : Normal                  
Abanan : Constipation, Noctural polyuria, frequency of micturation.  
Viyanan : Symmetrical sensory disturbances, Peripheral neuritis, pain all over 
the body. Burning sensation in the sole of foot and palm, skin 
infection and carbuncle. 
Udanan : Exessive thirst.  
Samanan : Poly Phagia 
Nagan : Normal 
Koorman : Diabetic retinopathy / Cataract 
Kirukaran : polyphagia 
Devathathan : Normal 
Thananjeyan :     - 
 
Azhal: 
Sites of Pitha: 
 Between the heart and the naval, sweat, lymph, blood, stomach, urinary bladder, 
heart, saliva, eye and skin. 
Properties: 
 Dry, cold, hot, light, subtle, keen, soft, liquid, bitter. 
Function: 
Body temperature, digestion of food,colouring of the skin, vision,sweat. 
In Neerizhivu: 
 Anala Pitham    - Excess hunger 
 Ranjaga pitham - Pallor sometimes 
 Alosagapitham - Diminishing of vision 
 Saathaga pitham - Lassitude 
 Pirasaga pitham - Dry skin 
Iyam: 
Sites of Kapha: 
Above the heart, stomach, fat, sperm, tongue, uvula, bone marrow, blood, nose, 
nerves, bones, large intestine, eyes, joints. 
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Properties: 
 Heavy, cold, mild, watery, sweet stable and slimmy. 
Function: 
Iyam gives streanth, builts the body, gives streanth for joints,gives shiney 
appearece to skin, moistens food,cools the eyes,gives a whitish colour to the conjuctiva 
skin,urine and faecal matter,softness,firmness the capacity to bear or endure,patience.  
 
In Neerizhivu  
 Avalambagam  - Normal 
 Tharpagam  - Burning sensation in the eye 
 Santhigam  - Joint pain 
 Kilethagam  - Excessive appetite 
 Pothagam  - Normal 
 
Seven Udal Thathukkal (Physical constituents):  
     Annamaya kosa is constituted by seven thathus.They are the basic tissues of our body. 
Normal functions: 
Saram: 
 It is responsible for the growth and development.  It keeps the individual in good 
spirit and it nourishes the blood. 
Senneer: 
 Blood imparts colour to the body and nourishes the muscle responsible for the 
ability, intellect of the individual. 
Oon: 
        It gives shape to the body according to the requirements for the physical activity, 
nourishes fat. 
Kozhuppu: 
         It helps in lubricating the different organs and maintains only matter of the body. 
Enbu 
      Supports the system and responsible for posture and movements of the body. 
Moolai: 
       It fills the bony cavity, nourishes semen, imparts strength endurance and shining 
appearance. 
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Sukkilam / Suronitham: 
  It is responsible for reproduction.  In healthy people, they function in a harmony, 
while in diseased people, they are deranged. 
In Neerizhivu: 
 Saaram  : Tiredness, General weakness 
 Senneer  : Pallor 
 Oon   : Lean and thin 
 Kozhuppu  : Dry skin 
 Enbu   : Later stage due to infection it affects the   
                bone and sometimes leads to amputation. 
 Moolai         : Affected in Chronic stage. 
Sukkilam / Suronitham: Impotence, Sexual urge is reduced. 
 So, in Madhumegam, Seven Udal Thathukkal are deranged. 
 
MUKKUTRA VERUPADUGAL-(SIDDHA PATHOLOGY):  
“gfu; gpj;j tpe;ijayhJ Nkfk; tuhJ” –Njiuau;;. 
The disease megaroham, due to external (or) internal causes affect balance in the 
ratio of vali, Azhal, Iyam.  This imbalance affects the Keelnokkukal, which inturn affect 
the seven udal thathukkal.   Saram gets affected and there is loss of appetite.  Seeneer also 
get affected with the net result even if the patient eats more nourished food (polyphagia) 
there won’t be any improvement in health. 
 An imbalance in pitham does imply an imbalance in other two kutrams too and 
causes derangement of dasa vayu and seven udal thathukkal which cause the disease and 
other complications. 
“FwpAlNd Nkfe;jhd; nfhLik nra;J 
Fiwe;J te;J tUe;jhJ nty;yhq; Fd;wpg; NghFk;” 
gjpnzz;rpj;ju ehb Ehy;;.; 
 
PINIARI MURAIMAI- (DIAGNOSIS): 
Diagnostic methods in Siddha system are very unique and solely based on clinical 
acumen of the physician. 
1. Poriyal Arithal (or) understanding by the fire organs of perception (Mei, Vai, 
Kann, Mooku,    Sevi) 
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2. Pulanal Arithal (or) understanding by the sense objects (Uraithal, Suvaithal, 
Parthal, Mugarthal, and Kettal). 
3. Vinadal (or) Interrogation 
           The physician using his organs of perception and senses examines the patient     
and diagnoses the disease. Apart from this, on effective history taking also helps one to 
diagnose property. 
 
Tools used by Siddha Physicians: 
(1) Kanndal (Perception) 
(2) Karuthal (Inference) 
(3) Oorai (The instruction of the inspired) 
                 (njh.».M) g - 46 
 The application of these three is very extensive in diagnosis and treatment. 
 
“Enn Vagai Thervu (Eight tools of Diagnosis) 
juzpAs;s tpahjp jd;id al;lhq;fj;jhy; 
     jhdwpa Ntz;LtJ NaNjh ntd;dpy; 
jpuzpaNjhu; ehb fz;fs; rj;jj;NjhL 
     Njfj;jpdJ guprk; tUzk; ehf;F 
apuz ky%j;jpukh kpit fnsl;Lk;  
     apjk; glNtjhd; ghu;j;Jf; Fwpg;Gq;fz;L 
guzUshy; ngupNahu;fs; ghjk; Nghw;wpg; 
     gz;G jtwhky; gz;bjQ; nra;tPNu” 
                Fzthfl ehb. g - 112 
Naa: 
The tongue is the organ of taste and speech. Naa is one of the Gnanenthirium. 
Colour of the tongue, size, shape, anomalies, surface, mobility and local lesion should be 
noted. Coating deposition of the tongue, increased salivation, and dryness of the tongue. 
Pervested taste, tongue ties must be noted.character of speech is noted in mozhi. Mozhi is 
one of 5 kanmenthiriyam. 
  Neer Bhoothams is related tongue which makes it wet always.  
 In Neerizhivu the tongue remains dry and at times black.  
In Neerizhivu, the tongue remains dry and at times black. 
Niram: 
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Colour of the skin all over the body, a local region of affection, conjunctiva, tongue, nail 
bud, hair etc. 
Colour changes in the excretion from Nava thuvaram is noted (i.e) we have to observe 
colour changes in malam, muthiram, vomited matter, sputum, saliva, semen, teeth and 
face. 
 Vatha Udal  - Black and whitish colour 
 Pitha Udal  - Yellowish (or) Reddish colour 
 Kapha udal  - White or golden colour 
 Thontha udal  - Mix of two udal colours 
 
In Neerizhivu, the colour of skin is different from original complexion, discoloured. 
Mozhi: 
 To quote from Agasthiar Vallathi 
 “th®¤ijia¥ gh®” 
Observation of speech and voice.The different components of speech should be 
properly as curtained. 
Voice is a sound produced by the speech organ and uttered by mouth .In 96 thathuvas vai 
(mouth)one of  the Gnanethiriyams and Mozhi one of the kanmenthiriyams.it belongs to 
Akaya Bootham. 
 In uncontrolled Neerizhivu which leads to cerebrovascular disorder, speech 
disorder sets in. 
Vizhi: 
 Colour, character, vision should be observed.Apart from any discharge chronic 
diseases can be identified. 
 In uncontrolled Neerizhivu cataract set in last.  In longstanding cases, the 
Neerizhivu affects retina and causes diabetic retinopathy which is the major cause of 
blindness. 
Sparisam: 
          Therayar quates “nka;f;Fwp” 
Colour of the skin (Vali, Azhal, Iyya udal), Eruption, Hemorrhages, Ulcers, Boils, trophic 
changes, in the skin can be identified. 
Any changes in the internal organs can be noted by palpation (or) percussion. 
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 In Neerizhivu, increased tendency for fungal infection like moniliasis and 
vulvities. 
Necrobiosis lipoidica diabeticorum the usual site in pre labial surface of lower 
limb and non healing ulcers in foot. 
 In Neerizhivu the skin is dry and pale. 
Malam: 
             To quote from therayar “,Ukyk;” three times evacuation of bowel is must.  
 Quantity, colour, smell, froth should be observed. 
            In Neerizhivu, constipation sometimes yellowish loose stool are passed. 
Muthiram: 
 Quantity colour froth smell and specific gravity of urine should be noted. 
 
ePupd; nghJ FwpFzk:  
    “te;j ePu;f;fup vil kzk; Eiu vQ;rnyd; 
     iwe;jpaYsit aiwFJ KiwNa”;  
Urine: 
Colour: 
 In Neerizhivu clear and white. 
Specific Gravity: 
 In Neerizhivu, urine is thick in consistency like honey. 
Smell: 
 Honey like smell, In diabetic keto acidosis,the urine has fruit smell.  
Froths: 
 In Neerizhivu the urine is frothy at the time of urination. 
Deposits: 
 In Neerizhivu few epithelial cells are present in urine. 
 Normal quantity of adult urine is 750 – 2500 ml in 24 hours. 
In Neerizhivu polyuriya is present.Both quantity and frequency of urine are increased. 
Disturbing   polyuria at night (nocturia) and Glucosuria (the presence of sugar in urine) 
are present. 
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Ú® ãw¡F¿: 
 “mUªJ kh¿ujK« ménuhjkjhŒ 
  m~fš my®jš mfhyñ‹ jé®ªjH‰ 
  F‰wstUªÂ cw§» itfiw 
  Mo¡fyr¤ jhéna fhJ bgŒ 
  bjhUKT®¤j¡ fiy¡F£gL Úç‹ 
  ãw¡F¿ beŒ¡F¿ ãUä¤jš flnd” 
nehŒ ehlš 1 g – 198 
Collection of Sample Urine: 
 The patient must take well cooked food in the previous day.  The intake must be 
proportionate to the degree of his appetite.  Food intake should be taken, at appropriate 
time.  We must have sound sleep on the previous night.  The urine is collected on the 
down of the next day in a glass container and closed immediately to prevent 
contamination.  This specimen must be examination with in one and half hours.  This 
procedure should be followed strictly to get accurate observation of Neerkuri and Neikuri. 
beŒF¿: 
 “ãw¡F¿¡ Fiu¤j ãUkhz Úç‰ 
 Áw¡f bt©bzŒnah® ÁWJë eL éL¤ 
 bj‹Dw¤ Âwªjbtë nafh  jik¤jÂ 
 å‹wÂtiy ngh« be¿éêa¿Î« 
 br‹wJ òfYª brŒÂia Íznu”   
nehŒ ehlš 1   g- 209 
NEIKURI: 
 The diagnosis and prognosis of deranged Mukkutrams are studied on the bais of 
the behaviour of a drop of gingelly oil gently droped on the surface of the urine kept in a 
wide vessel in the sunlight. 
 “K¤bjh¤J ã‰»‹ bkhHtbj‹ fgnk” 
            nehŒ ehlš 1  g-209. 
In Neerizhivu, the oil dropped in urine is like a pearl and if the oil spreads slowly, 
the prognosis of the disease is slow and good. 
eho: 
 Pulse diagnosis is the confirmatory diagnosis.  In Neerizhivu, 
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 ÏUäna Ã¤jK« thjK§ Tooš 
 kUÎry nkf« thUÂ nghyhF« 
 cUt« ntwhU K©lÎl‹ fhªÂL« 
 cUfnt ñndhL c¿ŠÁ Ïå¡Fnk” 
ÂU_y® Á¤j kU¤Jt« g- 487 
The above poem says that excessive elimination of urine containing sugar are 
always primarily due to continued vitiation of Azhal and Vazhi.Functional factors in the 
body ,the vitiation of “Azhal vazhi” is indicated clinically by excessive 
hunger,thirst,emaciationandpassing of large quantity of urine. 
“JhuzKld; ePu;g;ghL Neu;ghlhdhy; 
nrhy;Yfpd;Nwd; ehbnay;yhk; jsu;e;J fhZk;” 
gupG+uz ehb g - 150  
From the above lines,all the three Naadies are feeble and week in Neerizhivu patients. 
kJnkf Fz«: 
“Ïå¡»‹w  thj¤ Âilnrçš Iaªjh‹ 
gå¡»‹w fŸS¥ gjånghš ÚnuhL« 
få¡»‹w nkå fiuªJ btS¥ngW« 
jå¡F« kJnkfª j¥ghJ Iand” 
ÂU_y® Á¤j kU¤Jt« g- 488 
        The coupling of the Vali and Iya naadi causes increase tension in azhal Naadi. This 
is called “kudila naadi” it causes Neerizhivu urine is like today patient is emerciated. 
 
thj¤Jl‹   Ány¤Jk«  To   nkf éahÂ 
V‰g£lhš    fŸSgjå¥   ngh Ú® btë¥gL« 
nkY«clš    FiyªJ     btS¤j   ãw« 
bfhŸS«    Ïj‰F   kJnkf«    v‹W bga® 
    gÂbd‹  Á¤j®fŸ  eho  rh°Âu«-  g¡f« 89. 
When kabha merges with vadha, glucosuria, emaciation, anaemia, develops. 
 
gh®¤ÂL  _‹W« gÂªJ   bkèªJ   ã‰»š 
nj®ªÂL  nk tª  njh‹¿na    bghUªÂbkŒæš   
- ÂU_y® eho g-110 
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When all  the  three nadis ,runs in low volume,diabetes develops. 
“gw;gpj;j Nkf nkd;why gpj;j kPSk; 
ghyfNd fhq;if nfhz;L ePuhk; ghNu” 
 
From the above lines,it is clearly stated that vitiation of Azhal results in Neerizhivu. 
“ePu;Nkf khdtu;f;F ehb jhDk; 
 ePu;;kakha; ehbnay;yhk gyNk nfl;Lf; 
fhh;Nkfk; Nghyte; njupNky; Guz;L 
  tpOg;GOg NghyNt Guz;L fhl;Lk;”;;;;                      
gupG+uz ehb g - 155 
All the three Naadies are felt feeble in these suffering from “Meganoi”. The 
chrater of the pulse is compared to that of wrigging movements of a worm that have 
fallen in to the fire.  
 
cWjpAs;s gpj;jkJ Njhd;wpy;…….. 
…………..gpuNkfq;fs;…………… 
                  rjf ehb. 
The above stanzas are indicating vitiation of Azhal, resulting Neerizhivu. 
 
ÚuêÎ nehæš fhQ« mt¤ijfŸ: 
 
The following complication follow gradually.  If the disease is not controlled (or) left 
untreated. 
mt¤ij – 1 
 “fhznt Kjty¤ij¢  rßuª  jhD« 
fdkhf¥ gU¤ÂWF Ú®¤J thu« 
ntznt bt©lh¡» afy« g©Q«” 
     -Á¤j kU¤Jt« g- 483 
Obesity sets in. 
There is obstruction in urinary flow. 
Urinary passage expands due to inflammation. 
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mt¤ij – 2 
  “ä¡f Ïu©L lhkt¤ij és«g¡ nfshŒ 
_znt _¤Âu¥ ÔilÍkh¢ R¡y 
KfkG»¤ nj#Rjh‹ äfnt F‹W«” 
Á¤j kU¤Jt« g – 483 
Micturation is frequent. 
Sexual desire gets. 
There is also loss of complexion. 
mt¤ij – 3 
  “ehznt  _‹whF  kt¤ij¡ Fªjh‹ 
ehtwS« thÍtJ ÛWªjhnd” 
Á¤j kU¤Jt« g – 483 
Tongue generally becomes dry. 
Abdomen is distended due to flatulence. 
mt¤ij – 4 
 “jhdhd ehyt¤ij a§f jhf« 
r‹åaJ ghj K©lh«” 
 Á¤j kU¤Jt« g- 483 
Severe thrist occurs. 
Causes delirium 
mt¤ij – 5 
 “IªJ t¤ij¤ 
njwhd Ú®bgUfª jhJ eZl« 
Á¤j kU¤Jt« g- 483 
Quantify of urine increased. 
Loss of semen (impotence). 
mt¤ij – 6 
“ãiy ahwh kt¤ijÍl‰ »il bfhŸshJ 
_dhd _®¢ir tU«” 
Sleeplessness is present. 
Difficulty in breathing is experienced. 
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mt¤ij – 7 
“VGt¤ij 
ä¡ftnuh ÁfŠRthrª njf rh£a«” 
Á¤j kU¤Jt« g- 483 
Tongue becomes tasteless. 
Difficulty in breathing is experienced. 
General weakness persists. 
mt¤ij – 8 
“Vdhd v£lht jt¤ij jhnd 
vG»uªÂ ÃsitÍªjh‹ äfÎ©lhnk” 
Á¤j kU¤Jt« g – 483 
Abscess is formed. 
Presence of Carbuncle. 
mt¤ij – 9 
“c©lhF bkh‹gjh kt¤ij nfshŒ 
  xG§fhd Mrhu§ »Uä Í©lh«” 
    Á¤j kU¤Jt« g – 483 
Irregularities in daily habits like bowel habits. 
Bed soar may occur. 
mt¤ij – 10 
 “g©lhd g¤jhªj it¤ij¡ nfshŒ 
  ghukh«  ra§f©L gu¤J¡nfF«” 
Á¤j kU¤Jt« g - 483 
Secondary infection like tuberculosis may sets indue to loss of immunity, 
Other complication loading to death may occur. 
These are the complication at 20 Neerizhivu. 
Other complications: Meganeer Kattigal 10. 
 Madaku Katti 
 Ammaiodu Kattai 
 Valai Kann Katti 
 Athomuga Katti 
 Phai surai katti 
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 Kadalai katti 
 Kadugu Katti 
 Vithirathi Katti 
 Nilapoosani katti 
 Magavithirathi katti 
 
ÔU«  Ôuhjit  (Prognosis) 
brŒant t¢rukhª j©l khd 
brakhd KJFj©il¥ g‰¿ ã‰F« 
bgŒant bgUeu«Ãš nkfªjhD« 
Ãw¡Fbk‹nw jhd¿ªJ thjªj‹dhš 
ÃŒant Ãwªjfy  khwh yrh¤Âa« 
Ã¤j¤Â‰ Ãwªjry khW« ah¥a« 
igant  nr£Lk¤Â‰ Ãwªj g¤J« 
gukDiu¤ jh® rh¤a« guhgç¡nf” 
ô» it¤Âa Áªjhkâ  g- 156 
“MdJ gpj;je; jd;dp yhwQ; Nrw;gdk; gj; 
  jPdkhk; thj ehd;fh kpjpy; thjk; jPuh ePNu” 
guuhr Nrfuk; g- 22 
“têÍ« thj«  eh‹fhnk khwh jéœjª j‹dhny 
 bghêÍ« thj«  ãšyhJ nghnk kUªij¥ bghŒbadnt” 
njiua® thfl«  g-42 
The four types of megam caused as a result of  imbalance  of vali are incurable. 
The six types of megam arising with disparity of Azhal could be cured with great 
difficulty. 
But ten types of megam arising due to Iyyam are curable. 
vªbjªj nuhf§fëš ÁWÚ® mÂfç¤jhY« FiwªjhY« ÔJ 
“bt¥ò  Ãâajåš bt«nkf¤jhš tUªÂ‹ 
j¥ò äif Únu jhåw§»‹ - br¥ò« 
»uhâæ‰ gh©oš Fs®Ú® RU§»‰ 
Ãuhz‹ ÃçÍbkd¥ ngR” 
 (f©Qrhäa«) nehŒ ehlš1  g – 153 
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Very excess of urination in Megaroham causes death. 
“JÂ¥ghd nkf¤Âš ÚçêÎ khfh 
njh‹¿a  ÚçêÎ j©Ù® thjKkhfh” 
                                         (rjf eho) nehŒehlš  1   g – 153 
If Megaroham is associated with excessive urination, it is difficult to cure.  If megaroham 
coexist with vali it is incurable. 
“nkf¤Âš ÚçêÎ nkÎkÂš thj nehŒ 
ntf tæ¤JŸ tæ‰WisÎ – nrhf é¡fš 
g‹D é¡»š j‹åš gfçis¥ò¥  gh§f jå‰ 
Ã‹dis ahfhJ ngR” 
nehŒehlš  1  g – 153 
In megaroham, if Valinoi, excurating pain in abdomen hiccough and tuberculosis coexist 
it is incurable. 
“Úç‰ Ãsit ãU«Ãsitæš jhf« 
XJ kÂš njf¤Jiw kdYª – njUkÂš 
nrhU ka¡fKŠ brhš ka¡f¤Âš éa®it 
Mç‰Öjh bk‹w¿” 
nehŒehlš 1 -  g – 154 
If in complications of  Megaroham with carbuncle, Morbid thrist, excessive body heat, 
shock and sweat occurs the prognosis is bad. 
“nt®itjå‰ fgK« nkÎkÂš é¡fš nehŒ 
  fh®K»š ne® TªjyhŒ f©L nkš – Ó®bfhŸ 
kU¤Jt¤Â‰nw®ªj kÂÍilahuhé 
jç¤Âuh bj‹g®rç”              
nehŒehlš 1 -  g – 154 
If Iya megam is associated with sweat hiccough, the prognosis is bad. 
Maruthuvam: 
“itj;jpar; nray; itj;jpakhNk”- jpU%yu; 8000 
The treatment in Siddha Medicine is aimed at keeping the three kutrams (Vali, 
Azhal and Iyam) in equilibrium and maintenance of the seven udal thathukal. 
“cw;whd sTk; gpzpasTq; fhyKq;  
fw;whd; fUjpr; nray;” ; 
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In siddha science, the treatment is not only for removal of the disease, but for the 
prevention and improving the body condition after the removal of the disease. 
 
This is classified as 
 Kaappu -Prevention 
 Neekam -Treatment 
 Niraivu -Restoration  
Kaappu: 
 Prevention is better than cure is a proverb.   Siddha principles based mainly on 
prevention as mentioned in “Theraiyar pini Annuga vithi” by Theraiyar. 
 The aim of the treatment is to bring the affected thathus and Mukkutram to normal 
levels by eyamma, niyamma, diet and medicine. 
The rules affecting healthy alliance have been elabourately described in the science of 
Astrology.The ideal marriage life should be on the basis of physical, emotional, 
intellectual and social compatabilities. 
NEEKAM: 
  The mukkutrams are responsible for organisation, regularisation and integration 
of the body structures and their physio psychological functions which are kept in a state 
of equilibrium by word, throught, deed and food of the individual. The general 
actiological factors for constitutional discomfort is said to be incompatible diet, mentel 
and physical activities. 
 When treating the disease the following principles are noted. 
“cw;whd sTk; gpzpasTq; fhyKq;  
fw;whd; fUjpr; nray;” ;  
 For the disease neerizhivu, serrankottai thiravagam 10 drops twice daily with 
water before food.    
Niraivu: 
 Physical, Psychological, social and economic rehabilitation of individual is known 
as Niraivu. 
 In Madhumegam, Azhal kutram and other two kutrams Vali and Iyam deranged 
and cause impairment of dasavayu which in turn affect the seven udal thathukkal. 
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Line of Treatment: 
“gf®Ã¤j éªijayhJ nkf« tuhJ” 
Neha;ehly;-1 g.254 
    
The aim of treatment in Neerizhivu is to normalize the vitiated mukkutram, vayus 
and theaffected seven udal kattugal.As this disease is caused by megam ,suitable effective 
medicinal preparations have to be administrated in the beginning itself  to neutralize and 
eliminate the megam from the body tissue. 
 
Siddhrs aimed at bringing the mukkutram in equilibrium as the basis of the 
treatment ofdisease. Initially the patient will be treated with herbs,if is not effective 
mineral preparations are used while treating  the disease. Siddhars prescribed a minimum 
dosage initially and then increased the dose gradually. 
“Ntu;ghU jiog;ghU kpQ;rpdf;fhy; 
nky;ynky;y gw;g nre;Jhuk; ghNu.” 
There are many preparations for Neerizhivu and its complications found in 
various siddha textbooks, like kudineer, choornam, maathirai, ilagam, parpam, 
chendhuram, thiravagam, etc. 
Theran maruthuva Bharatham; 
“fpue;jpg; Gz;zpuz Nkff;  
fPr;rf ndd;De; Jd; khu;f;f 
dUe;jp nad;Dk ghQ;rhyp 
ad;idiaf; fz;Zw;whNd”     ;  
Neerizhivu has been caused by indulgence of sex.It leads to the formation of 
meham which gradually all the seven udal kattugal and finally sets in genitourinary 
system, resulting in excessive secretion and elimination of urine with sweet taste. 
     In Theran Maruthuva Bharatham, meham is alluded to keesagam and Neerizhivu 
(madhumegam) is alluded to sainthavan. So the pancha pandavas who killed these 
keesagan and sainthavan.  
        In Neerizhivu seven udal thathukkals are affected. In Theran Maruthuva Bharatham 
some paadanam and metals are alluded to pancha pandavas for streanthening the seven 
udal thathukkal. 
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Saaram;  
     Abscess, boils, carbuncles, cellulitis, fungal bacterial infections are common 
when saaram is affected. Gandhagam (sulphur) is alluded to paanchali. To streangthen 
the saaram we used to give drug of Gandhagam. 
Senneer; 
Diabetic foot, gangrene and impotence are common due to vascular insufficiency. 
Ayam (iron) is alluded to Dharman. Ayam preparations are given to streangthen the 
senneer. 
Oonn; 
When the oonn is affected diabetic polyneuropathy will occur i.e weakness and 
wasting of the proximal muscles, loss of weight (Neuropathic cachexia) hyperasthesia, 
parasthesia with pulmonary tuberculosis are seen. To streangthen the oonn velli (silver) 
is given velli is alluded to Sagadevan. 
Kozhuppu and Enbu 
 Impotence, pulmonary tuberculosis and emaciation supervene. Pon (Gold) 
preparations are given tostreangthen the kozhuppu and enbu.pon is alluded to abimanyu. 
Moolai and sukkilam; 
Diabetic polyneuropathy and impotence may occur.prepared medicine of 
kaareeyam (lead) and sembu is alluded to Arjunan.  
Nutritional Approach: 
        Lifestyle modifications are the cornerstone of management of diabetes mellitus 
and include the prescription of a healthy diet, regular exercise, the management of stress, 
and avoidance of tobacco 
The approach consists of provisions of adequate calories for maintaining or 
attaining standard weight for age sex and height. 
General consensus on proportion of food constituents are 
Carbohydrate 60 – 65 % (complex form have more fibre) 
Fat 20 – 25 % (saturated 7.8 % polyunsaturated 7-8% Mono unsaturated 7.7%) Proteins 
10 – 15 % 
Diet and nutrition has very important role in disease like Neerizhivu. Diseases are 
largely due to irregular dietary habits.  The body requires no medicine no it new food is 
eaten only after the food that has already eaten before is fully digested and the food 
agrees with body.    
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Diet 
The aims of dietary management are to achieve and maintain ideal body weight, 
euglycemia and desirable lipid profile, prevent and postpone complications related to 
diabetes and to provide optimal nutrition during pregnancy, lactation, growth, old age 
and associated conditions e.g. hypertension and catabolic illnesses. 
The dietary recommendations should be individualized according to person's 
ethnicity, cultural and family background, and personal preferences and associated co-
morbid conditions. It should be flexible in variety and preparation of food choices and 
timing of meals according to person's daily routine. 
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REVIEW OF MODERN LITERATURE 
MODERN ASPECT 
CONCEPTS OF DIABETES: 
Diabetes is one of the ancient disease.The history of diabetes is stated in the Ebers 
papyrus(1500BC) polyuria and honey urine was noted as early as 400B.C by our  Indian 
physician “susruta”.He has described this disease as Madhumegam,the honey is the urine. 
   At present it is commonly known as “sugar in urine”. In older days it was also 
known as melting of flesh.In Greek “diabetes”means “pass through” and in Latin 
“mellitus” means “honey” i.e presence of sugar in the urine. 
   This disease has been known to ancient Indian, chinesh, Arabic and Roman 
physicians.In 1674 Thomas wllis for the first time distinguish diabetes mellitus by the 
taste of urine. In 1688 Brunner removed the pancreas in dogs. In 1773 D0bson established 
that the urine sweet in diabetes mellitus because of the sugar in it. 
   In 1835 discovery of excess sugar in the blood in diabetes mellitus belongs to 
Ambrosiami. In 1855 Claude Bernand discovery of glucosuria in animal. In 1869 
Langerhans found accumumalations of special cells in the pancrease, which lates were 
named “Islets of Langerhans” .Rassian scientist ULezko-stroganova was the first to 
emphasize the endocrine role of “Langerhans” is lets in 1881. Insulin affects carbohydrate 
metabolism was demonstrated by Mynkowsky and mehring in 1889-1892. In 1892 
Mynkowsky first removed pancrease from a dog. 
 Canadian scientists Banting and Best in 1921 obtaining insulin from the 
pancrease of nnew born  calf.The first insulin in the USSR was produced in 1922 under 
the supervision of  Eigorn. 
 In 1936 Howsay demonstrated for the first time that besides Insulin.other 
hormones participate in the pathogenesis of diabetes mellitus.In 1942-1946 Loubatieres 
gave  a explanation to many facts concerning the mechanism of  action of sulphonyhreas 
in diabetes mellitus.In 1955 the English man Sanger established the molecular structure 
of insulin.    
 The synthesis of human crystalline insulin was accomplished by kastoyannis in 
the USA in 1963, and by zahn and fellow-workers in 1965.In 1972 a group of scientists 
leaded by Yudayev and sLvachkin in the USSR accomplished the laboratory synthesis of 
insulin that is identical with human insulin. 
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   All the achievement in the past, the present diabetic can almost have a normal life 
span with usual activities by their diet.exexise, medicine and hygiene.The mortality was 
more due to diabetic coma, but now the longevity has increased by modern medicine. 
   Now a days the cause of death among diabetes with the onset at young age is due 
to diabetic nephrophathy and in adults, it is due to vascular disease. 
 
DEFINITION: 
Diabetes mellitus is a clinical syndrome, characterized by hyperglycemia due to 
absolute or relative deficiency of insulin. 
   Lake of insulin affects the metabolism of carbohydrate protein, fat, and causes 
asignificant disturbance of water and electrolyte homeostasis.Death may result from acute 
metabolic decompensation while long-standing metabolic derangement is frequently 
associated with permanent and irreversible functional and structural changes in the cells 
of the body, with those of the vascular system being particularly susceptible. 
These changes lead to the development of well defined clinical entities the so, 
called complication of diabetes.which characteristically affect the eye, the kidney,and the 
nervous system.  
ANATOMY OF PANCREAS: 
Definition: 
 The pancreas(pan=all,kreas=flesh)is a gland that is partly exocrine and partly 
endocrine.The exocrine part secretes the digestive pancreatic juice;and the endocrine part 
secretes hormones like insulin.it is soft ,lobulated and elongated organ. 
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LOCATION: 
The pancreas lies more or less transversely across the posterior abdominal wall, at 
the level of first and second lumbar vertebrae. 
 
SIZE AND SHAPE: 
Pancrease is j-shaped or retort, set obliquely.the bowl of the retort represents its 
head, and the stem of the retort,its neck,body and tail. It is about 15-20cm long, 2.5-3.8cm 
broad and 1.2-1.8cm thick and weights about 90g. 
 The pancreas is divided (from right to left) into the head,the neck,the body and the 
tail.The hedd is enlarged and lies within the concavity of the duodenum.The tail reaches 
the hilum of the spleen.The entire organ lies posterior to stomach separated from it by the 
lesser sac. 
 
Head of the pancreas: 
 Definition: 
       Head is the enlarged flattened right end of the pancreas,situated within the curve 
of the duodenum. 
 External features: 
The head has three borders, superior, inferior, right lateral; twosurfaces, anterior 
and posterior; and one process, called the urcinate. This projects from the lower and left 
part of the head towards the left. 
Relations: 
The superior border is overlapped by the first part of the duedonum and is related 
to the superior pancreaticoduodenal artery.The inferior border is related to the third part 
of the duodenum and to the inferior pancreaticoduodenal artery.The right lateral border is 
related to the second part of the duodenum, the terminal part of the bile of the bile duct 
and the anastamosis between the two pancreaticoduodenal arteries. 
The anterior surface is related, from above downwards, to: 1) the gastroduodenal 
artery; 2) the transverse colon, and3) the jejunum which is separated from it by 
peritoneum. 
  The posterior surface is related to: 1)the inferior vena cava,2)the terminal parts of 
the renal veins,3)the right crus of the diaphragm and 4)the bile duct which runs 
downwards and to the right and often embedded in the substance of pancreas.  
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Uncinate process: 
   It is related anteriorly to the superior mesenteric vessels, and posteriorly to the 
aorta 
 
RELATIONS OF PANCREAS 
 
 
Neck of the pancreas: 
This is the slightly constricted part of the pancreas between its head and body.it is 
directed forwards, upwards and to the left.it has two surfaces, anterior and posterior. 
 
Relations: 
   The anterior surface is related toto:1) the peritoneum covering the posterior wall 
of the lesser sac,and 2)the pylorus.At its  junction with the head there lie the 
gastroduodenal and superior pancreaticoduodenal arteries. 
  The posterior surface is related to the termination of the superior mesenteric vein 
and the beginning of the portal vein. 
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Body of the pancreas: 
Defination: 
 The body of the pancreas is elongated.it extends from its neck to the tail.It passes 
towards the left with a slight upward and backward inclination.  
External features: 
 It is triangular on cross-section,and has three borders(anterior,superior and 
inferior).A part of the body projects upwarts beyond the rest of  the superior border,a little 
to the left of the neck. This projection is known as the tuber omentale. 
Relations: 
Three borders 
 The anterior border provides attachment to the root of the transverse 
mesocolon.The superior border is related to celiac trunk over the tuber omentale,the 
hepatic artery to the right,and the splenic artery to the left.The inferior border is related to 
to the superior mesenteric vessels at its end. 
Three surfaces 
 The anterior surface is concave and directed forwards and upwards.It is covered 
by peritoneum. And is related to the lesser sac and to the stomach. 
The posterior surface is devoid of peritoneum, and is related to  
1) The aorta with the origin of the superior mesenteric artery, 
2) The left crus of the diaphragm. 
3) The suprarenal gland, 
4) The left kidney, 
5) The left renal vessels,and  
6) The spleenic vein. 
The inferior surfaces is covered by peritoneum,and is related to the 
duodenojejunal flexure,coils of jejunum and the left coliac flexure. 
 The tuber omentale projects upwards beyond the lesser curvature of the stomach, 
and is related to the lesser omentum across the lesser sac.it is the relationship to the 
omentum that gives process its name. 
Tail of the pancreas: 
This is the narrow left end of the pancreas. It lies in the linorenal ligament 
together with the splenic vessels.it comes into contact with the lower part of the gastric 
surface of the spleen. 
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DUCT OF THE PANCREAS: 
PARTS OF PANCREAS 
 
 
 
 The exocrine pancreas is drained by two ducts, main and accessory. 
1) The main pancreatic duct of wirsung lies near  the posterior surface of the pancreas 
and is recognized easily by its white colour .I t begins at the tail;runs towards the 
right through the body;and bends at the neck to run downwards,backwards and to the 
right in the head. 
2) Its lumen is about 3mm in diameter. 
3) It receives numerous small tributaries which join it at right angles to its long axis 
forming what has been described as a ‘herring bone pattern’. 
4) Within the head of the pancreas the pancreatic duct is related to the bile duct which 
lies on its right side.The two ducts enter the wall of the second part of the duodenum 
and join to form the hepatiopancreatic ampulla of vater which opens by a narrow 
mouth on the summit of major duodenal papilla, 8to10 cm distal to the pylorus. 
5) The accessory pancreatic duct of santorini begins in the lower part of the 
head,crosses the front of the main duct with which it communicates and opens into 
the duodenum aat the minor duodenal papilla.This papilla is situated 6to8 cm  distal 
to the pylorus.The opening of the accessory duct lies cranial and ventral to the main 
duct.The two ducts remind the double origin of  pancreas from the ventral and dorsal 
pancreatic buds.  
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Arterial supply: 
 The pancreas is supplied:  
1) Mainly by pancreatic branches of the spleenic artery, 
2) The superior pancreaticoduodenal artery and  
3) The inferior pancreaticoduodenal artery 
 Like the duodenum the pancreas develops at the junction of the foregut and 
midgut, and is supplied by branches derived from both the celiac and superior 
mesenteric arteries. 
Venous drainage: 
  Veins drain into spleenic, superior mesenteric and portal veins. 
Lymphatic drainage: 
  Lymphatics follow the arteries and drain into the pancreaticosplenic, celiac and 
superior mesenteric groups of lymph nodes. 
Nerve supply 
1) Sympathetic  
a) coliac plexus 
b) Superior mesenteric plexus 
     2) Parasympathetic 
a) vagus nerve 
Endocrine pancreas 
 The endocrine part of the gland is formed by the islets of Langerhan’s.  
These islets are arranged into irregular plates.  Tortuous blood capillaries supply 
them the cells are poly hedral in shape.   The islemts are surrounded by awnar 
cells.  There are about 2 million islets in the human pancreas.  Each islet is about 
200-300 micron in size. 
 
Major cell Types: 
1. Beta (β) cells: Comprise about 70% of islet cells and secrete insulin, the 
defective response (or) deficient synthesis of which causes diabetes 
mellities. 
2. Alpha (  )   cells: Comprise 20 % of islet cells and secrets glucagons 
which induces hyperglycemia.  
3. Delta (  ) Cells: Comprise 5 to 10 % of islet cells and secrete 
somatostatin which suppresses both insulin and glucagons release. 
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4. Pancreatic Poly peptide (P.P) cells (or) F Cells: Comprise 1 to 2 % of 
islet cells sand secrete pancreatic polypeptide having some gastrointestinal 
effects. 
A. Minor Cell Types:   
1. D1 Cells elaborate vasoactive intestinal peptide (VIP), which induces 
glycogenolysis and hyperglycemia and causes secretory diarrhea by stimulation 
of gastro intestinal fluid secretion. 
2. Enterochromaff in cells: 
Synthesise serotonin, which in pancreatic tumours may induce carcinoid 
syndrome. 
  
Physiology of the pancreas: 
1. Functions of Exo crine pancreas: 
 The main functions of the exocrine pancreas are the alkaline secretion of 
digestive enzymes prominent among which are trypsin, chymotrypsin, Lactase, 
amylase, lipase and Phospholipase.  
2. Functions of Endocrine Pancreas: 
 The endocrine portion of the gland the islets of Langerhans produce the 
hormones insulin and glucagons that play a key role in carbohydrate metabolism. 
 
ISLET CELL STRUCTURE: 
 The islets of langerharns are ovoid, scattered throughout the pancrease, 
although they are more plentiful in the tail in the body and head.In humans, there 
are 1-2 million islets. 
 The cells in the islets can be divided into types on the basis of their 
staining properties and morphology.There are atleast four distinct cell types in 
humans.A,B,D and F cells.A,B and D cells are also called α,βand δ cells. 
  A cells 20  secretes Glucagon 
  B cells 75% secretes Insulin 
  D cells 5-10% secretes somatostain 
  F cell   1-2% secretes pancreatic polypeptide. 
  D cell 5-10% secretes vasoactive intestinal polypeptide. 
   Entro chromatin cells secrete serotonin. 
  The B cells is the predominant cell type that make up 
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INSULIN: 
 Insulin is secreted by Bcell or the beta cells in the islets of Langerhans of 
pancreas. It has molecular weight of 5808and contains 2 amino acid chains 
linked by disulfide bridges. Alpha chains of insulin contain 21 amino acids and 
beta chain contains 30 amino acids. 
 Insulin is a polypeptide containing two chains of amino acids linked by 
disulfide bridges Insulin is synthesized in the endoplasmic reticulam of the β 
cells.  The half life of insulin in the circulation in humans is about 5 minutes. 
 
EFFECTS OF INSULIN:  
 
They are conveniently divided into rapid, intermediate and delayed actions. 
 
Rapid  Seconds) 
Increased transport of glucose, amino acids and K+ 
into insulin sensitive cells. 
 
Intermediate 
(Minutes) 
Stimulation of Protein Synthesis 
 
Inhibition of protein degradation 
 
Activation of glycogen synthesis and glycolytic 
Enzymes 
 
Inhibition of Phosphorylase and gluconeogenic 
enzymes. 
 
Delayed (hour) 
Increase in MRANS for lipogenic and other 
enzymes. 
 
 
 The net effect of the hormone is storage of Carbohydrate, Protein, and fat.  
Therefore insulin is appropriately called the ‘hormone of abundance’ total daily 
release in man is about 50 IU out of a pancreatic store of 200-250 IU of insulin. 
 
EFFECT OF INSULIN ON CARBOHYDRATE METABOLISM: 
To facilitate rapid update storage and use of glucose by almost all tissues 
of the body mainly by muscles adipose tissue and liver. 
Insulin Promotes muscle glucose uptake of metabolism: 
  Insulin facilitates the uptake of glucose by muscle and excess glucose is 
stored as glycogen. 
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Insulin Promotes liver uptake, Storage and use of Glucose: 
Mechanism: 
  There is increase in the uptake of glucose by liver cells and also in the 
activity of enzymes that leads to glycogen synthesis.  It in activates those 
enzymes that cause glycogen breakdown.  Glucose is released from the liver, as 
blood glucose decreases Insulin converts excess glucose into fatty acids and 
inhibit neoglucogenesis in the liver. 
          
 II. EFFECT OF INSULIN ON PROTEIN METABOLISM & GROWTH:  
1. Insulin promotes protein synthesis and storage.  It facilitates the 
transport of amino acid into cell.  
2. There is increase transcription of DNA and translation of messenger 
RNA. 
3. Decrease catabolism of proteins is there 
4. It decease the rate of gluconeogenesis  
5. Insulin lack leads to protein depletion and increase the amino acids. 
6. Insulin and growth hormone acts synergistically to promote growth. 
 
EFFECTS OF INSULIN ON FAT METABOLISM:   
 Insulin promotes fat synthesis and storage mechanism.  It increases the 
utilization of glucose by most of the body tissues which automatically decrease 
the utilization of fat thus, functioning as ‘fat sparer’. 
 Insulin also promotes fatty acid synthesis.  Almost all synthesis occur in liver 
cells and fatty acids are transported from liver by way of blood lipoproteins to the 
adipose tissue to be stored.  It decreases the hormone sensitive lipase, thus 
preventing hydrolysis of triglycerides. 
Insulin Deficiency leads to: 
 Lipolysis of storage fat and release of free fatty acids. 
 Increased synthesis of plasma cholesterol and phospholipids concentration. 
 Excess use of fat during insulin lack causes ketosis and Acidosis. 
 Excess acetoacetic acid is formed in the liver cells. 
 Decrease utilization of aceto acetic acid in the peripheral tissues, thus so 
much of it   is released from the liver that is cannot alebe metabolized by 
the tissue. 
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Role of Insulin in switching between carbohydrate and lipid metabolism:   
  Insulin promotes utilization of carbohydrate for energy and it will decrease the 
utilization of fat. Lack of insulin causes utilization of fat instead of glucose.  The 
signal that controls the switching mechanism is principally blood glucose.  So the 
role of insulin in the body is to control which these two foods (glucose & fat) will 
be used by the cells for energy. 
 
BLOOD GLUCOSE REGULATION: 
 
1. Liver has an important blood glucose buffer system. 
2. Both insulin and glucagon functions as an important feedback control 
system for maintaining normal glucose concentration. 
3. Decreased glucose stimulates sympathetic nervous system. 
4. Growth hormone and cortisol are secreted in response of decreased blood 
glucose. 
 
IMPORTANCE OF BLOOD GLUCOSE REGULATIONS: 
 
 Glucose is the only nutrient for brain, retina and germinal epithelium of 
the gonads. 
 It is important to maintain that blood glucose should not rise to high 
since. 
 Increased osmotic pressure in extra cellular fluid leads to cellular 
dehydration.  
 Increased glucose loss in urine 
 Osmotic diuresis by the Kidney. 
 Long term increase leads to vascular damage. 
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METABOLIC EFFECTS OF INSULIN AND GLUCAGONS: 
 
Metabolic effects Insulin Glucagons 
Secretion Stimulated Hyper Glycemia Hpoglycemia 
Blood Glucose Decrease Increase 
Liver glycogen Increase Decrease 
Gluconeogenesis Decrease Increase 
Protein Synthesis Increase Decrease 
Fatty acid synthesis Increase Decrease 
Triglyceride break 
down 
Decrease Increase 
Glucose utilization Increase  
 
 
CLASSIFICATION: 
PRIMARY DIABETES MELLITUS: 
 
  1. Insulin dependent diabetes mellitus, immune dependent diabetes 
melltitus (IDDM) (or) type 1 (or) insulinopenic (or) juvenile onset diabetes 
(JOD) (1% to 20%). 
  In some individuals in later life a slow progression to insulin deficiency 
only occurs which is called latent auto immune diabetes of adults (LADA).  This 
is associated with marked weight loss, un responsive hyperglycaemia with oral 
drugs.  Pronenes to ketosis and presence of auto antibody. 
  2. Non insulin dependent diabetics mellitus.  Non immune dependent 
Diabetics mellitus (NIDDM) (or) maturity onset diabetes mellitus (MOD) (or) 
Type II Diabetes (80% - 90%). 
  This is very commonly seen in adults and rarely in the yong.  The cause is 
usually unknown.  In most of these patients tissue insensitivity to insulin has 
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been found (genetic).  This is at times more aggravated by ageing and visceral 
obesity of abdomen.  There is also a lack of response of β cells to glucose and 
hyperglycaemia.  Thus both these factors viz tissue insensitivity to insulin and 
lack of Betacell response to glucose are very important basic factors for the 
development of type II diabetes type II diabetes may be again to two types. 
 
A.  OBESE: 
  Here diabetes is secondary to extra pancreatic factors which local to 
insensitivity to endogenous insulin. 
 
B. NON OBESE: 
  These patients generally show a blunted response (or) no response as 
regards insulin secretion after glucose load but albeit to other insulinogenic 
stimuli. Eg IX sulfonylurea, Glucagon (or) Secretin. They generally respond well 
to therapeutic oral hypoglycemic agents.  In this group the following types are 
also seen. 
I. MILD FORM OF TYPE I DIABETES:   
 Beta cell mass is contracted they become insulin dependent. 
II. MATURITY ONSET DIABETES OF THE YOUNG (MODY) 
 There is a strong family history for Mody now five types of this syndrome 
have been identified. 
SECONDARY DIABETES MELLITUS: 
1. Non – Pancreatic endo crinal disorders 
 Acromegaly 
 Cushing’s Syndrome 
 Thyrotoxicosis 
 Phaeochromocytoma 
 Glycagonoma 
2. Pancreatic disease 
 Chronic Pancreatitis 
 Carcinoma of pancreas 
 Pancreatic Calculi. 
 Cystic fibrosis 
 Pancreatectomy 
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3. Drug induced: 
 Steroids 
 Thiazide diuretics 
 Contraceptive pills etc. 
4. Miscellaneous: 
 Mumps 
 Rubella 
 Insulin receptor antibodies. 
 
WHO CLASSIFICATION: 
1. Diabetes Mellitus: 
 (a) Insulin dependent diabetes mellitus – IDDM type I 
 (b) Non insulin dependent diabetes mellitus- NIDDMType II 
  (i)  Obese 
  (ii) Non obese 
 (c) Mal nutrition related diabetes mellitus – MRDM. 
 (d) Other types – Secondary 
  Hormonal 
  Drug induced 
  Pancreatic 
  Other abnormalities. 
1. Impaired glucose tolerance – IGT 
2. Gestational diabetes mellitus – GDM. 
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3. DIFFERENCE BETWEEN TYPE I & TYPE II  DIABETES 
 
 
 
AETIOLOGY: 
 
Age:  NIDDM occurs chiefly in middle aged individuals. 
Sex   :  Both sexes suffer equally.  But in lower age groups males and in middle 
age groups females are more affected. 
Heredity: 
 If may run in families but there is complicating evidence for the made of 
inheritance.  NIDDM has a greater hereditary component. 
Stress and Strain: 
 Physical and mental stress (or) strain may be responsible of the disease as 
counter regulatory hormones are secreted in excess. 
 
S. 
No. 
 
Type  I Type  II 
1. Age <  30 years  >  30 years 
2. Seasonal incidence Present Absent 
3. Autoimmunity To islet cell, insulities, 
other autoimmune disease 
Not present 
 
 
4. Heredity HLA – DR3 (or)  
DR4 > 90% 
NO HLA Connection 
5. Clinical Markedly emaciated 
classical symptoms are 
present 
Merkedly  obese 
classical symptoms 
usually lacking. 
6. Serum Insulin Less (or) Nil May be less (or) more 
7. Kelo acidosis Prone Not so 
8. C-Peptide Disappears Remains 
9. Treatment By insulin Oral hypoglycaemic 
drugs rarely insulin. 
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Infection: 
 Seasonal variations with winter and autumn peaks of increased incidence of 
diabetes have been described.  These possibly indicate some environmental 
factors (or) infective factors in the causation of diabetes coxsackie B4 virus, 
rubella and encephalomia carditis may cause islet cell dysfunction 
Obesity: 
 Two major mechanisms have been proposed for the tissue insensitivity to 
insulin in cases of obecity. 
(i)   Prolonged beta cell stimulation may lead to hyper insulin giving rise to 
receptor insensitivity. 
They may be post receptor defect. 
 Histo Compatibility antigen (HLA –System) 
 About 95% of types 1 subject are having either HLA DR3 (or) HLA DR4. 
Auto Immune Mechanism: 
 Diabetes is seen to be associated with various auto immune diseases such as 
myxoedema and Addison’s disease. 
Hyperglucagonaemia: 
 In IDDM hyperglucagonaemia is present. 
Diet: 
 Bovine serum Albumin in milk may be an initiating factor in infancy when 
cow’s milk is taken. Various nitrosoamines, coffee, gluten are also for 
development of IDDM. 
HORMONAL ANTAGONISTS TO INSULIN 
1. Growth Hormone – Acromegaly 
  Growth hormone hyper secretion affects the metabolism.  So clinical 
diabetes mellitus (10%) occurs. 
2. Gluco carticoids – Cushing’s syndrome 
  Hyper fuction of the adrenal gland Cushing’s syndrome is defined as the 
symptoms and signs associated with prolonged in appropriate elevation of free 
corticosteroid levels.  Increased gluconeogenesis may lead to impaired glucose 
tolerance.  So diabeties mellitus occurs. 
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3. Thyroid hormone – Hyper thryoidism: 
 In hyper thyroidism rapid rise of blood glucose follows a meal and the 
concentration exceeds the normal renal threshold, during this time glucose will 
be present in the urine. 
4. Catecholamine excess: 
 Tumor is found in adrenal medulla excess of catecholamine produced.  This 
causes glucose intolerance.  So diabeties occurs. 
PATHOGENESIS: 
 It is a complex affair and is still for from clear, Lack of insulin, presence of 
insulin antagonists, excessive neoglucogenesis, viral infection HLA system, 
heredity, auto immunity jointly (or) in proportion are possibly responsible for the 
development of diabeties. 
 Due to lack of insulin blood sugar level steadily rises and when it crosses the 
renal threshold level of 180mg/ 100cc glycosuria results.  Renal threshould level 
however varies with age and pregnancy.  Glucose increases the osmolarity of 
glomerular fillrate and also backs the obligatory volume of water during 
elimination. This result in profuse diruresis even up to 10 to 15 liters per day 
associated with hyponatraemia, hypokalaemia and hypomagnesaemia. Thus 
intense thirst, dehydration shock and crystalloid imbalance may develop.  
 Again as sugar is not burnt, adequately for energy requirement, fat is 
mobilized from the adipose tissues and large quantities of free acid circulate in 
the blood.  Normally these are burnt in the liver.  But as these are produced in 
large quantities of acetone which accumulate in the blood and ultimately appear 
in urine and breath. 
 Several hormones particularly the growth hormone may help in this process 
incompletely metabolized carbohydrate Eg. Pyruvic acid and lactic acid also 
accumulate in the blood.  This condition is called diabetic keto acidosis which 
often leads to coma and death. 
 Liver is enlarged due to fat infiltration and blood contains enormous amount 
of neutral fat and various hormones may act as insulin antagonists.  Apart from 
there, insulin antibodies may be produced in the blood.  Lastly due to continuous 
loss of sugar in the urine the process of neoglucogenesis from protein maybe 
stimulated which may result in wasting of muscles and increased urinary loss of 
nitrogen. 
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CLINICAL FEATURES: 
 
  Onset is usually gradual but rarely there may be acute onset.  There may 
be no symptom (or) sign and the disease may be diagnosed during routine 
investigation (or) examination.  Sometimes patients may present features of 
complications of diabetes.  The classical features of diabetes may be seen as 
follows: 
Polyuria: 
  The amount of urine may be several litres in 24 hours.  This is due to 
excessive sugar in the urine which acts as a diuretic.  
Polydipsia (or) Excessive thirst: 
  Patient may consume several litres in 24 hours.  This is due to polyuria and 
hyper osmolarity of blood.  Blurred vision is also due to it. 
Poly phagia (or) Excessive hungers: 
  Patient always feel hungry and may have a craving for carbohydrate food, 
sweet, honey, sugar rice etc.  This symptom is due to non utilization of sugar for 
energy expenditure. 
Rapid emaciation: 
  There may be rapid loss of weight.  Initially it is due to loss of water, 
glycogen and triglyceride stores.  Gradually reduced muscle mass. 
Dryness of mouth and throat: 
  This is the effect of Poly uria. 
Constipation: 
 The stool becomes hard and bowel movement may take place after every 2 to 
3 days. 
Itching: 
  This is an important symptom and is located in the anus (or) external 
genitalia.  This is due to irritant action of sugar on the tissue and fungal (or) 
bacterial infections. 
Signs: 
  Clinical signs may be absent.  In IDDM cases emaciation may be a 
dominant feature.  Other signs depend on the presence of complications and 
degree of dehydration degree of consciousness may vary depending on the hyper 
osmolarity, ketosis, electrolyte imbalance and dehydration.  Loss of subcutaneous 
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fat and muscle wasting are important features of IDDM Hypotension is a serious 
sign with increased Chylomicrons and triglyceridemia, lipemia, liver is enlarged 
due to fat infiltration, chronic skin intection may be present.  In females, candidal 
valvo vaginitis, hydramnios, toximeas of pregnancy, unexplained fetal loss on 
birth of large babies are seen. 
 
Diagnosis: 
  Whenever diabeties is suspected the diagnosis should be confirmed by 
Glucose Tolerance Test (GTT) (or) more easily by fasting and post prandial 
blood sugar estimation.  For the first, the patient should take adequate 
carbohydrate diet (250) gm) for about 7 days (or) least for 3 days prior to the test.  
After an overnight fast of 8 to 12 hours in the early morning the fasting samples 
of blood and urine are collected.  After this the patients ingests 75gm of glucose 
(1.75 gm of glucose / kg of ideal body weight) dissolved in 250-300 cc of water.  
Following every half an hour of this blood samples  and  one hour of this urine 
samples are collected upto 2 ½ hours.  Now sugar level is estimated in all 
samples and in urine test for acetone is also done. 
 
Fasting blood sugar 
Normal fasting blood sugar level  - 80 – 120 mg% 
(But true glucose level will be less than this) 
Diagnostic fasting blood sugar level >140 mg%    (7.8 mmol /L) 
Post prandial blood sugar (2 hours after meals) 
Normal post prandial blood sugar level < 140 mg   (7.8 mmol / L) 
Diagnostic post prandial blood sugar level 200 mg% 
At risk for diabeties P.P.Sugar level 140 – 200 mg %  
 
According to WHO 
 Fasting Blood Sugar 
 Normal fasting Blood sugar level - <100 mg/ (6.1 mmol /L) 
 Impaired fasting glucose level (IFG) 100 mg% to 126 mg % (7mmol / L) 
 Diagnostic fasting blood sugar level > 126 mg% 
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GTT after 2 hours 
 Normal blood sugar level < 140 mg%  (7.8 mmol / L) 
 Imparied glucose tolerance (IGT) 140 mg % to 200 mg% 
 Diagnostic Blood sugar level > 200 mg % (110 / mmol / L) 
 Note: GTT is only required in border line cases and for diagnosis. 
Intravenous glucose tolerance test 
 It is done when there is gastro intestinal upsets (or) inadequate absorption of 
glucose is given IV and the fall of sugar level is observed in 1 ½ to 2 hours. 
Cortisone glucose tolerance test 
 50 mg of cortisone is given to the patient 8 hours and at 2 hours before oral 
GTT.  Sugar level is indicates the reserve capacity of beta cells or hyper 
glycaemia. 
Intravenous talbutamide test 
 After giving an IV dose (or) 1 gm of sodium talbutamide, blood sugar levels 
are estimated at 0, 20, 30 & 40 minuts, as talbutamide stimulates insulin secretion 
from beta cells.  This test indicates secretary capacity of insulin by beta cells. 
 
Serum insulin level during GTT 
Normal fasting insulin level 10 – 25 µu/cc 
Normal 1 hour insulin level   50 – 130 µu/cc 
Normal 2 hour insulin level < 10 µu / cc 
Unresponsiveness (or) insensitivity of glucose at 1 & 2 hours > 100 µu/cc 
 
Glycosylated Hb AI (C) 
                Normal level – 5 %   to 7 % 
The major form of HB AI (c) normally comprises 4% - 6% of total Hb.  The 
remaining 2 % - 4% of Hb is phosphorylated glucose (or) fructose and termed as 
HbIa and HbIb respectively. 
Serum Fructosamine level 
  Normal level 1.5 – 2.4 mmol / L.  When the serum albumin level is 5 
gm/dl. 
  When Hb AIc estimation become difficult due to abnormal Hb or 
Haemolytic state or in diabetic women recently becoming pregnant this 
assessment is advantageous. 
57 
 
Lipoprotein – abnormalities 
 In IDDM cases 
 Triglyceride - slight rise 
 LDL  - slight rise 
    HDL  - No change 
 
Insulin Resistance cases 
 Triglyceride - High 
 LDL  - Qualitative change in LDL particles. 
 HDL  - Low 
Urine: 
 Normally sugar is absent.  When the blood sugar level croses the renal 
threshould level of 130 mg% sugar appear in the urine.  But in presence of high 
renal threshold level three to no glycosuria.  Again when the threshold is low, 
sugar is present in urine (Renal glycosuria).   Threrefore glycosuria cannot be 
accepted as diagnostic of diabetes.  Some drugs interfere with the determination 
of sugar in urine and false negative results are obtained.  These drugs are vitamin 
C, Salicylate, methyldopa and leuodopa.  Kelone bodies in urine at a time 
indicate diabetic keto acidosis. 
 
Causes of Glycosuria:   
  Diabetes Mellitus: 
This is very common cause of glycosuria in elderly patient. 
 Renal glycosuria 
Low Renal threshold sugar comes out in the urine  
 Alimentary glycosuria 
After ingestion of 500gm of glucose sugar may appear in the urine. 
 
Complications of Diabetes: 
 Virtually every tissue and organ is biochemically and structurally altered 
as a consequence of the hyperglycemia of diabetes.  These for the complications 
of the disease. Two biochemical mechanisms appear to be involved in the 
development of many complication.  In the first glucose reversibly bind to the 
body proteins.  This is a non enzymatic event that can cause structural and 
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functional abnormalities of the involved proteins.  The concentration of 
glycosylated hemoglobin in the blood is now used clinically as a measure of 
therapeutic control. 
 The second biochemical mechanism operates in the aorta, lens of the eye, 
Kidney and peripheral nerves.  These tissues are endowed with an enzyme, 
aldose reductase that facilitates the accumulation of sorbital and fructose in cells 
of the hyperglycemic patient.  As a result of the intracellular accumulation of 
sorbital and fructose an osmotic gradient is established and excessive amounts of 
water enter the cells from the extra cellular compartment.  The cells then swell 
and are damaged.  
 
ACUTE COMPLICATIONS: 
Hypoglycaemia:  
 Hypoglycaemia, defined as a blood glucose concentration of less the 2.5 
mmol/L, occurs commonly in diabetic patients treated with insulin and 
infrequently in those taking a sulphonylurea drugs.  Severe hypoglycaemia result 
in severe morbidity ie coma, convulsion, brain damage, stroke, myocardial 
ischaemia, vitreous haemorrhage, hypothermia and accidents. 
 
Symptoms of Hypoglycaemia: 
 Sweating, trembling, hunger, anxiety, confusion, drowsiness, speech 
difficulty nausea, tiredness and headache. 
 
Diabetic ketoacidosis: 
   As a result of polyuria there will be dehydration, hyponatremia and 
hypopotassemia.  The intra cellular water comes out in the extra cellular space as 
a result of hyperosmolarity of the extracellular fluid due to increase of glucose. 
Plasma volume is decreased, blood pressure falls and renal blood flow is 
diminished resulting in oliguria.  The cellular glycogens and protein are 
catabolished. 
   Sugar is not burnt, fat is metablished from the adipose tissues and large 
quantities of free fatty acid circulate in the blood.  Normally these are burnt in the 
liver, into carbondi oxide and water.  But as these produced in large quantities. 
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   Acetyl to enzyme – A – accumulates and after condensation forms 
acetoacetic acid and its derivatives beta hydroxybutyric acid and acetone, which 
accumulate in the blood and ultimately appear in urine and breath.  Incompletely 
metabolised carbohydrate.  Eg pyruvic acid and lactic acid also accumulate in the 
blood.  This condition is called diabetic ketoacidosis. 
 
   When ketone bodies accumulate the plasma osmolarity is raised and the 
cells are further dehydrated ultimately ph of the blood falls.  This acidosis 
stimulates the respiratory centre where by pulmonary ventilation is increased 
giving rise to air hunger.  The breath contains the smell of acetone which is very 
diagnostic of this condition.  The function of the brain cell is depressed and 
gradually Como supervenes. 
 
CLINICAL FEATURE: 
 Patient is usually dehydrated, with sunken eyes dry skin and tongue and 
prominent malar bones.  The ocular tension is low (Krauss’s sign).  There is 
kussmaul’s air hunger with hissing respiration.  Bp is usually low, pulse is low in 
volume, oliguria, abdomen may be regid and tender, vomiting, smell of acetone 
is present in the breath, diminished reflexes, Ketonuria, glycosuria, blood shows 
hyper glycaemia and reduced plasma bicarbonates, evidence of insection eg, 
boils, carbuncles and respiratory wact injection are very common patient may be 
couscious initially but gradually drowsiness and coma supervene. 
 
NON-KETOTIC, HYPEROSMALAR COMA 
 In this condition due to very high blood sugar level dehydration occurs, 
leading to dehydration of the brain cells resulting in coma and convulsion.  
Marked elevation of BUN and creatinine is seen in this condition.  But no 
ketoacidosis. 
 
CHRONIC COMPLICATIONS: 
OCULAR COMPLICATION: 
1. Diabetic Cataract 
 There may be senile cataract with clouding of the lens.  Sometimes, true 
diabetic cataract may develop and in seen in juvenile cases. 
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2. Diabetic Retinopathy 
 This consists of venous engorgement, Micro anaeurysm of the retina and 
hard exudates.  
3. Glaucoma develops in 6% cases. 
4. Error of retractions 
 Due to increased sugar content of the retractive media may develop. 
5. Iritus rubeosa 
 The papillary margin of the iris may become red due to micro aneurysm 
and this may lead glaucoma after words. 
6. Infection may develop complications of conjunctivae cornea, sclera and 
eyelid. 
7. Pupillary changes. 
 
SKIN COMPLICATIONS: 
 Skin infections are very common as sugar in tissues and sweat acts as a 
good media for bacterial growth, boils, carbuncles and fungal infections 
particularly monilial infection of vulva and penis are very common. 
 
COMPLICATIONS DUE TO DRUGS: 
 Hypoglycaemia coma, Allergic reaction, insulin Lipodystrophy in the site 
of injection, immune insulin resistance.  Cardio vascular complications with 
tolbutamide therapy and lactic acidosis with phenformin therapy may develop. 
 
VASCULAR COMPLICATIONS: 
 Macro vascular complications are very common.  Cerebral coronary, renal, 
limb arteries and abdominal aorta may be affected by the process of 
arteriosclerosis  due to this there may be ischaemic heart disease with (or) 
without thrombosis, cerebro vascular accident (CVA), ischaemic limb with (or) 
without gantene, renal artery stenosis etc. longer duration of disease,  advancing 
age, hyper insulenimia due to insulin resistance syndrome, obesity, 
Hyperlipidimia, particularly high triglyceride and low HDL, proteinuria and 
systolic hypertension will aggravate macro vascular complications.  
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RENAL COMPLICATIONS: 
1. Renal arteriosclerosis. 
2. Pyelo nephritis - This is very common and may lead to chronic renal 
failure. 
3. Micro albuminuria 
4. Papillitis, Necroticans- The renal papillae will show necrosis, ultimately 
leading to viaemia. 
5. Kimmelstiel – Wilson syndrome (K.W. syndrome)  
This is develops in average 10 years duration clinically patient will  
present feature of nephritic syndrome.  
 
NEUROLOGICAL COMPLICATION: 
 
1. Peripheral neuritis (30%) 
 It is very common in lower limbs.  There may be poly neuropathy, 
Mononeuritis, painful neuropathy,  Trophic ulcer may also develop. 
2. Autonomic imbalance 
 Impotency, postural hypotension, nocturnal diarrhea, loss of sweating, 
nocturnal sweating, cardiac irregularities, fixed pulse rate, resting 
tachycardia, sudden death, cold feet, pedal oedema, small pupil, delayed 
light reflex, resistance to mydriaties etc may develop. 
3. Diabetic amyotrophy 
 This consists of wasting, weakness of pelvic girdle muscle and thigh 
muscles. 
4. Different cerebro vascular accidents. 
5. Charcot’s joint 
 
Sexual and Genital Complications: 
 Impotence and frigidity may develop erectile dysfunction in males is 
particularly important.  Balanitis and Balanoposthitis are common complications 
in males.  These are due to secondary infection as urine contains heavy amount 
of sugar and nitrogenous materials. Leucorrhoea may develop in females. 
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Pulmonary complications: 
 Tuberculosis is very common in diabetes other infective complications like 
pneumonia, bronchopneumonia, pleurisy etc. 
 
Effects on pregnancy and neonates: 
 There may be miscarriages and abortions toxaemias of pregnancy, 
hydramios etc Herculian child may be born of diabetic mothers due to secretion 
of excess of growth hormone. 
 
TREATMENT: 
1. Diet regime 
2. Diet and oral hypoglycaemia agents 
3. Diet and insulin 
4. Special treatment for complications. 
 
Diet regime: 
 Obese diabetics are to be given a reducing diet.  On the other hand lean 
and thin diabetics should given a weight gaining diet.  In case of mild diabetes 
with obesity diet control alone is required. 
 Ideal calorie requirement is 20 calories per kg of body weight 
 Protein requirement is 1 – 1.5 gm per kg of body weight for adults & 2-
3gm per kg of body weight for children. 
 Carbohydrate requirement is 2 gm per kg body weight. 
In practice 40% to 60% of the total calorie should come from carbohydrate.  
Total fat should be < 35% of the energy take.  Low fat products should be 
encouraged.  Regarding fat it is better to prescribe unsaturated fat to keep the 
cholesterol level under control.  A well balanced nutritions diet remains the 
fundamental key in the therapy of diabetes. 
 
CALCULATION: 
 Ideal weight of an adult is 60 kg. 
 Therefore, the total calorie requirement will be 60 x 20 = 1200 kilo calorie. 
 Protein requirement = 60 x 1 = 60 g   which is gives 60 x 4.1` = 240 kilo 
calories. 
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 Carbohydrate requirement = 40 % of 1200 kilo calories 40% of 1200 kilo 
calories = 480 kilo calories.  i.e. 120 gm of carbohydrate give = 480 kilo 
carlories (430 -4 = 120) 
 Thus protein and carbohydrate will make about (240 + 430) – 720 kilo 
carlories. 
 Fat will yield about 1200 – 720 = 480 kilo calories which may be obtained 
from 480  9.1 = 52 gm of fat. 
 Thus a patient of about 60 kg will require  
Protein  - 60gm 
Fat  - 52 gm 
Carbohydrate- 120 gm 
Many patients require between 1800 and 2500 kilo calories and women 
require a little less than this.  For growing children, pregnant mothers (or) hard 
working labourers’ provisions for additional calories should always be made. 
Fibre Diet: 
 Plant components eg.  Cellulose, gum and pectin are not digested and are 
termed dietary fibre.  In soluble fibres eg, cellulose (or) hemi cellulose which are 
present in bran increase intestinal transit and other soluble fibres eg, Gums, 
pectin, etc which present in beans, apple skin and oat meal try to retard intestinal 
absorption.  Therefore the later fibres will minimize glucose absorption and 
hence minimize hyperglycaemia.  Moreover, these high soluble fibres have some 
cholesterol lowering property. 
 Salt 
      Salt in the diet should not be 6gm/day but it should be less in case of 
hypertention. 
Vitamins and antioxidants; 
  These should be quite adequate in diet menu of diabetic patients. 
Nutritional Approach: 
       Lifestyle modifications are the cornerstone of management of diabetes mellitus and 
include the prescription of a healthy diet, regular exercise, the management of stress, and 
avoidance of tobacco 
The approach consists of provisions of adequate calories for maintaining or 
attaining standard weight for age sex and height. 
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General consensus on proportion of food constituents are 
 Carbohydrate 60 – 65 % (complex form have more fibre) 
Fat 20 – 25 % (saturated 7.8 % polyunsaturated 7-8% Mono unsaturated 7.7%) Proteins 
10 – 15 % 
Disease like Madhumegam has very important role in diet and Nutrition.  Diseases 
are largely due to irregular dietary habits.  The body requires no medicine no it new food 
is eaten only after the food that has already eaten before is fully digested and the food 
agrees with body.    
Diet: 
The aims of dietary management are to achieve and maintain ideal body weight, 
euglycemia and desirable lipid profile, prevent and postpone complications related to 
diabetes and to provide optimal nutrition during pregnancy, lactation, growth, old age 
and associated conditions e.g. hypertension and catabolic illnesses. 
 
The dietary recommendations should be individualized according to person's 
ethnicity, cultural and family background, and personal preferences and associated co-
morbid conditions. It should be flexible in variety and preparation of food choices and 
timing of meals according to person's daily routine. 
 
Dietary Recommendations: 
Total Calorie Intake:  
The calorie requirements of diabetic person depend on physical activity and 
nutritional status as in a normal individual, unless there is glycosuria. Individual with > 
120% of ideal weight is considered overweight and < 90% of ideal weight is underweight. 
The ideal body weight (IBW) is calculated by formula: 
IBW = (height in cm - 100) x 0.9  
The caloric intake of person with diabetes should be altered gradually, preferably not 
more than 500 Kcal per day.  
Total calorie distribution:  
a) Carbohydrate (55-60% of total calorie requirement) 
• Avoid sugar, honey, jaggery and sweets. 
• Restrict processed refined food like maida-based products. 
• Main source should be cereals, mixed coarse grains, whole pulses, salads and 
soybeans. 
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• Roots and tubers should be used sparingly. 
b) Fibers 
Traditional Indian diet is rich in fibers. Fiber rich foods include whole grains (ragi, 
jowhar, barley, oats etc.), whole pulses, soybean, green leafy vegetables and fenu-greek 
seeds.  
c) Protein (10-15% of total calorie requirement): 
Protein from vegetable sources, low fat milk and milk products, fish and lean meat is 
preferable.  
d) Fat (20-25% of total calorie requirement): 
 Saturated fat - <7% of total caloric intake (including ghee and butter) 
 Rest should be in from of MUFA and PUFA 
 N6/N3 ratio = 5-10 
 Trans-fatty acid (hydrogenated vegetable oils) should be avoided. 
 Dietary cholesterol should be minimal and in any case should not exceed  300mg 
per day. 
 Use more than one edible oil. 
 Oils containing linoleic acid (n-6) only such as ground nut, sesame, cotton seed, 
rice bran and safflower should be used along with oils containing a-linoleic acid 
(n-3) such as soyabean, mustard, canola etc. 
e) Fruits: 
Whole fruits are recommended in moderation (1-2 servings), however, very sweet 
fruits and fruit juices should be avoided.  
 Artificial sweeteners: 
Use of artificial sweeteners in limited quantity is acceptable but they are to be avoided 
During pregnancy and lactation. 
f) Common salt: 
Up to 6g/day is permitted. Restrict pickles, papad, chatni and salty processed foods. 
Alcohol δ Tobacco 
 Alcohol intake is best avoided and if used, must be in moderation. It may 
exacerbate 
Neuropathy, dyslipidemia, obesity and may worsen the control of diabetes. 
 Smoking and the use of tobacco in any form should be prohibited. 
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DIABETIC DIET REGIME 
 
DIABETES PATIENTS WERE ADVISED TO TAKE FOOD IN THEFOLLOWING 
MANNER 
 
Time Food regime 
Morning           6.00 
Coffee/Tea/ 
Milk(without sugar)/1cup 
Morning           8.30 Idly -2/dosai-2/chappathi -2/pongal-1 cup 
Morning           11. 00 
Butter milk -1cup/lemon juice/vegetable soup/ 
Any fruit -1 
Afternoon         1.00 
Rice -2 cup/chappathi -3/sambar/ kerai koottu/poriyal/ 
rasam/butter milk 
Evening            4.00 Moong dal -1 cup/any  pulses/coffee/tea 
Evening            6.00 any fruit-1 
Night               -8.00 Chappathi-2/rice -1 cup/idly -2/dosai -2 
Before bedtime 
milk without sugar -1 cup 
 
 
EATING RULES FOR DIABETICS 
 
  People suffering from diabetes should follow certain rules during eating.  
 
  For diabetics, water or any other liquid is recommended only after half an hour after 
a meal. But if a person wishes, he can drink water or any liquid half an hour before 
eating but not during eating. 
 Food should not be eaten hurriedly by diabetic person. Food should be eaten very 
slowly and chewed properly. 
 Diabetic patient should not keep fast as missing of meal which may be highly 
dangerous. 
 Diabetics should never eat to a full stomach.  
 Diabetic patient should not smoke or drink alcohol while eating. 
 In a people with diabetes, the raw vegetables and raw fruits should not be taken 
together. 
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 After a principal meal, they should not do any heavy work. 
 Diabetics should take 5-6 small, frequent meals rather than 3 big meals. 
 They should take 15-20 glasses of water daily to avoid constipation. 
 Diabetic persons should discard the skin of chicken pieces as it contains fat. 
 If a diabetic feel giddy, it indicates that the blood glucose level has fallen, a 
condition known as hypoglycemia. So, in this condition they must immediately eat 
energy giving food like apple or drunken fruit juices. 
 They should have normal eating at correct times and at regular time intervals. 
 During eating, if sodium is to be restricted then they should avoid spinach, peas, 
carrot. 
 
nkf« ÏUgJ¡F« g¤Âa« 
 
 gRnkf äUgJ¡F g¤Â  aªjh‹ 
  gh§fhf Îiu¤Âlnt gRé‹ bt©bzŒ 
 bghçthf vUik nkh® bgh‹dh§fhâ 
  ng®bg‰w ÁWÑiu KR£il ahF« 
 Mçthf mtiubahL òlš KU§if 
  mÂrukh§  f©L  rU¡  fiuÍ  khF« 
 kçthf khjisah« ngß¤ jhF« 
  kfhés« gHKªÂç¥ gHK khnk 
 Mnkng a‹ thiH¥ gHK§ f¢rš 
  m¤Âæl¥ ÃŠRÁW gaWgHŠ nrhW 
 ghnkgHŠ nrh‰WÚ® btªjaŠ Óufkh« 
  ghfš Õç¡ f§fhŒfU nt¥Ãiy bfh¤jkè 
 nenkbe‰ bgh¿ vŸS KRKR¡if ahF« 
  neuhd ešby©bzŒ ò©z¡FSªJ 
 jhnkf äUgJ¡F« g¤a t®¡f« 
  rh‰¿dh® Át‹whDª jhŒ¡F¤ jhnd. 
 
                                                      ô» it¤Âa Áªjhkâ – 156 
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The following foods are preferable to the diabetics 
 
Ñiu tiffŸ (Greens)  fhŒf¿fŸ (Vegetables) 
 bgh‹dh§f©â   mtiu 
 ÁWÑiu     òzš KU§if 
 KR£il     thiH f¢rš 
 bfh¤j kšè    m¤Â ÃŠR 
 fUnt¥Ãiy    ghfš 
 KRKR¡if    Õ®¡F 
 
bfhG¥ò bghU£fŸ (Fat)  éij (Seed) 
gRé‹ bt©bzŒ   btªja« 
vUik nkh®    Óuf« 
ešby©bzŒ    vŸ 
 
khÎ bghUŸ (Carbohydrate)  éij (Seed) 
gHŠnrhW     ÁWgæW 
gHŠnrhW  Ú®    cSªJ 
be‰bgh¿ 
 
 
The few fat substance has curative nature against Madhumegam that is 
Cow’s butter cures prameg 
Buffalo’s butter milk cures thrist 
Gingelly oil cures disease of eyes, ear, skin, infection like scabies, ulcer etc. 
In generally oil, lipid peroxidation is reduced and vascular complications risks are 
lessened.  
Most of the above foods used for Neerizhivu are ‘Sathva gunam” This clearly implies in 
Neerizhivu patients the stress level is very high and to reduce that stress improve 
tolerance of disease Sathvaguna foods are used. 
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PHYSICAL EXERCISES 
 
The need for walking is emphasized by Therayar as 
 “e©ò bgw Î©l Ã‹ò FWeilÍ§ bfhŸnth«” 
nju‹ ÃâaQfh éÂ 
. 
Regular physical exercise has important physiological and psychological benefits 
for all diabetes.  It should be followed 5 days a week for duration of 40 minutes each day 
and its severity should achieve 50 – 70 % of individual maximum oxygen up 
take.Diabetics may undertake any one of the simple exercises like ‘jogging, swimming 
and cycling etc….’ 
Dr. M.M.Ahuja. 
Simple sustained exercise like walking atleast 30 minutes is very important for 
diabetics.  
Dr. Mani S.B. 
Brisk walking for only 30 minutes a day was just effective as 1 ½ hours per week of 
vigorous exercise in reducing the risk of heart diseases (30-40% reduction). 
- ‘Rastrya Ratna’ Dr. T.Subramanian 
Benefits of Exercise: 
 
 Exercise helps in weight reduction. Appropriate exercise and diet control together 
are sufficient to control blood glucose levels in many mild type 2 DM patients 
thus avoiding drug treatment. 
 Exercise leads to lowering of blood pressure, which is commonly elevated in 
diabetes. 
 Exercise help in reducing blood levels of VLDL & LDL and increase the blood 
level of HDL cholesterol exercise improves blood circulation in the legs (Many 
long standing diabetics suffer from poor blood circulation in the legs.) 
 The ideal time to perform exercise is in the morning after a light snack. This  ill 
prevent hypoglycemic reactions 
 “Exercise training has been reported to improve whole body glucose metabolism 
in man and experimental animals. 
 Insulin mediated glucose uptake has significantly increased in skeletal muscle. 
 The glucose transporter isoform responsible for insulin and contraction – 
stimulated glucose uptake in skeletal muscle is termed  GLUT 4. The exercise 
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training increases GLUT 4 concentration in skeletal muscles and decreases 
hyperglycaemia.” 
- Endocrine journal (Japan) 
- Endorcrine Society Vol 49 Oct 2002 
Evaluation of the people with diabetes before exercise: 
 
 Before beginning an exercise programme, the individual with diabetes mellitus 
should undergo detailed medical evaluation with appropriate diagnostic studies. 
Strenuous physical activity including weight lifting should be avoided in the presence of 
coronary artery disease, proliferative diabetic retinopathy, nephropathy, and autonomic 
neuropathy. 
 Person with diabetes and coronary artery disease should be prescribed appropriate 
exercises after cardiac evaluation. 
 In proliferative diabetic retinopathy, strenuous activity like diving, weight lifting 
or bending may precipitate vitreous hemorrhage or retinal detachment. Walking may be 
continued. 
 Peripheral neuropathy results in loss of protective sensation in the feet. It is 
advised to wear proper footwear. The person with diabetes should be taught to monitor 
for blisters and other damages to the feet before and after exercise. 
 Autonomic neuropathy may limit an individual's exercise capacity and increase 
the risk of adverse cardiovascular events during exercise. 
  Person with diabetes and overt nephropathy often have reduced capacity to 
exercise. 
 
YOGA: 
 Yogic Physical exercise makes the muscles healthy and strong. It also tones up   
all the involuntary organs of the body which are concerned with the processes as 
digestion, evacation, circulation, respiration and secretion and through them, the 
autonomic nervous system which regulates their activities. 
-Yogic Aganas for health & Vigour. 
 
Gpuhzhahkk ( Pranayanam)-breathing excersice : 
Breathing is regulated with inspiration, expiration and retention of air in the ratio 
of 1: 2: 4 
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 On practicing pranayamam regularly, supply adequate oxygen to nerves cells. The 
cells of the brain and spinal cord consume much more oxygen. It makes the mind alert 
and improves concentration. 
V.G. Rali  
Specific Asanas for Diabetes – Dhanurasana  
     
 
jDuhrdk ;(Dhanurasana)- Bow pose 
 
 Lie flat on the Abdomen with the legs and feet together and the arms and hands 
beside the body. 
 Bend the knees and bring the heels close to the buttocks. 
 Clasp the hands around the ankles. 
 Place the chin on the floor. 
 This is the starting position. 
 Tightens the leg muscles and push the feet away from the body. Arch the back, 
lifting the thighs, chest and head together. 
 Keep the arms straight. 
 In the final position the head is tilted back and the abdomen supports the entire 
body on the floor. The only muscular contraction is in the legs; the back and arms 
remain relaxed. 
 Hold the final position for as long as it is comfortable and then slowly relaxing 
the leg muscles, lower the legs, chest and head to the starting position  
 Release the pose and relax in the prone position until the respiration returns to 
normal. 
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Benefits: The pancreas and adrenal glands are toned balancing the secretions. It is 
recommended in Yoga therapy for diabetes. 
 
gr;rpNkhj;jhrdk;(Pachimottanasana) -Back stretching pose 
 
 Sit on the floor with the legs outstretched, feet together and hands on the knees. 
 This is the starting position. 
 Relax the whole body 
 Slowly bend forward from the hips, sliding the hands down the legs. Try to grasp 
the big toes with the fingers and thumbs. If this is impossible, hold the heels, 
ankles or any part of the legs that can be reached comfortably. 
 Move slowly without forcing or jerking. 
 Hold the position for a few seconds. Relax the back and leg muscles allowing 
them to gently stretch. 
 Keeping the legs straight and utilizing the arm muscles, not the back muscles, 
begin to bend the elbows and gently bring the trunk down towards the legs, 
maintaining a firm grip on the toes, feet or legs. 
 Try to touch the knees with the forehead. Do not strain. 
 This is the final position. 
 Hold the position for as long as is comfortable and relax. 
 Slowly return to the starting position. 
 
Benefits: It tones and massages the entire abdominal and pelvic region including the 
liver, pancrease, Spleen, Kidneys and adrenal glands.   
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Miukr;rNae;jpuhrdk;(Arai  Matsyendrasana) : 
 
 Sit with the legs stretched out in front of the body. 
 Bend the right leg and place the right foot flat on the foot on the outside of the 
left knee. 
 The toes of the right foot should face forward.  
 Bend the left leg and bring the foot around to the right buttock. The outside edge 
of the foot should be in contact with floor. 
 Pass the left arm through the space between the chest and the right knee, and 
place it agains the outside of the right leg. 
 Hold the right foot or ankle with the left hand, so that the right knee is close to 
the left armpit. 
 Sit up as straight as possible. 
 Raise the right arm in front of the body and gaze at the fingertips.  
 Slowly twist to the right, simultaneously moving the arm, trunk and head. 
 Use the left arm as a lever against the right leg to twist the trunk as far as possible 
without using the back muscles. 
 Follow the tips of the fingers of the right hand with the gaze and look over the 
right shoulder. 
 Do not strain the back. 
 Bend the right elbow and place the arm around the back of the waist. The back of 
the right hand should wrap around the left side of the waist. 
 Alternatively, it can be placed as high as possible between the shoulder blades 
with the fingers pointing up. This arm position enforces the straightness of the 
spine.  
 Reverse the movements to come out of the posture and repeat on the other side.  
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`yhrdk (Halasana)- Plough pose 
 
 Lie flat on the back with the legs and feet together. Place the arms beside the 
body with the palms facing down.  
 Relax the whole body. 
 Raise both legs to the vertical position, keeping them straight and together, using 
only the abdominal muscles. 
 Press down on the arms and lift the buttocks, rolling the back away from the 
floor. Lower the legs over the head. 
 Do not force the toes to touch the floor. 
 Turn the palms up, bend the elbows and place the hands behind the ribcage to 
support the back as in sarvangasana.  
 Relax and hold the final pose for as long as is comfortable. 
 Return to the starting position by lowering the arms with the plams facing down, 
and then slowly lower the back and buttocks to the floor.  
 Raise the legs to the vertical position. Using the abdominal muscles, lower the 
legs to the starting position, keeping the knees straight 
 
Benefits: It promotes the production of insulin by the pancreas. It boosts the immune 
system. 
  
General Asanas: 
 Surya Namaskara  
 Savasana  
 Theraiyar clearly explains mild sunrays are much beneficial to our body to prevent 
diseases.  
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rthrdk;-Savasanam: 
 
 By doing savasanam, the whole body is relaxed and rejunuvate the body.  
 This Asana being practiced in the world for relaxation techniques. 
 Effect of Yoga Asanas on nerve conduction in Type II Diabetes.  
 Yoga asanas included “Suryanamskar, Konasan, Padmasan pranayam,  
Paschimottansan, Ardhmatsyendrasan, Shavasan. The yoga exercises were 
performed for 30-40 minutes every day 40 days in above sequence. The subjects were 
prescribed certain medicines and diet. 
Yoga asanas have a beneficial effect on glycaemic control and improve nerve 
function in mild to moderate type II diabetes with such clinical neuropathy. 
-Indian Journal physiology & Pharmacology 2002: 46 (3)  
                                                                                           Varun Malhotra etal 
 
Stress Management: 
Diagnosis of diabetes mellitus is a stressful situation in life of an individual and 
appropriate management requires a holistic approach that includes behavioral 
modification to develop positive attitude and healthy life style. A satisfactory treatment 
plan should include special attention to person with diabetes, quality of life, coping skills, 
optimal family support and a healthy workplace environment. Appropriate support and 
counseling is an essential component of the management at the time of diagnosis and 
throughout life. 
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PREPARATION OF TRIAL DRUGS 
 
PURIFICATION METHOD:  
Take serronkottai and boil it in Tarmarind leaf decoction, Butea monosperma 
flower decoction, Cow dungand Aleo Vera juice respectively. 
 
SERRONKOTTAI THIRAVAGAM:  
INGREDIENTS: 
Serronkottai seed- 2 ser (560 gm) 
 
PREPARATION: 
Take two ser purified serrankottai seed and smash into pieces.Then place it in a pot and 
add 1 pathakku (10.7 lit) water, soak the content for two days.Then transper distillation 
apparatus and heat it to get thiravagam.  
 
DOSE: 
          10 drops 
 
ADJUVANT: 
                     Water 
 
REFERENCE: 
                          Yagopu vaidhya chinthamani-700. 
 
 
 
 
 
 
 
 
 
 
SERRANKOTTAI 
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THIRAVAGA VAALAI 
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MATERIALS AND METHODS 
(PROTOCOL) 
STUDY DESIGN: 
       The open clinical trial on Neerizhivu was conducted at the OPD section of post 
graduates department of pothu maruthuvam, Government Siddha Medical College, 
Arignar Anna Hospital Chennai 600106 during the period of 2011-2013. 
 
SAMPIE SIZE: 
During this dissertation work on Neerizhivu (Diabetes Mellitus) totally 40 patient 
of both sexes in the age group above 40 are taken. 
 
INCLUTION CRITERIA: 
 Above 30 years of age 
 Both sexes 
 Non Insulin dependent diabetes mellitus 
 Poly uria 
 Poly Phagia 
 Poly dipsia 
 Nocturia 
 General weight loss 
 General weakness 
 Peripheral Neuritis 
 
Exclusion CRITERIA: 
 Insulin dependent diabetes mellitus. 
 Patients with hyperglycemia due to secondary causes like pancreatic pathology. 
 Patient with cardio vascular diseases.’ 
 Tuberculosis 
 Diabetic Nephropathy 
 Diabetic Retinopathy  
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TRIAL DRUG, DOSAGE, DURATION: 
INTERNAL DRUG:  
SEERANKOTTAI THIRAVAGAM -10 drops/tid with Water. 
TRIAL PERIOD: 48 DAYS. 
 
INVESTIGATION: 
 The investigations are carried out promptly and regularly before and after 
treatment. 
All patients are subjected to routine clinical investigation which include 
 Urine sugar-fasting and post – prandial 
 Albumin and deposits in urine  
 Total count, differential count, Erythrocyte sedimentation rate, Haemoglobin and 
urea, cholesterol in blood. 
 Blood Sugar, fasting and post prandial   investigations like glucose tolerance test, 
glycosylated Haemoglobin (HbA1c).  
Siddha system of clinical diagnosis 
 Poriyal Therthal  :   Mei, Vai, Kann, Mooku, Sevi 
 Pulanal Therthal  : Unarthal, Suvaithal, Parthal, Mugarthal, Kettal. 
 Venaathal             : 
 Mukkutra Nilaiga  :   Vali, Azhal, Iyam 
 Ezhu Udal Kattugal: Saaram, Senneer, Oon Kozhuppu, Enbu, Moolai, Sukkilam. 
 Envagai Thervu    : Naa, Niram, Mozhi, Vizhi, Naadi, Sparisam, Malam, 
Moothiram. 
 
Case sheet proforma: 
  Patients will be treated with clinical signs and symptoms of Neerizhivu 
Complaints and duration 
History of past illness 
Personal History 
Personal Habits 
Family History 
Systemic Examination 
Laboratory investication 
Prognosis of the disease and management. 
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PROPERTIS OF TRIAL DRUGS 
 
SERRONKOTTAI:  
Botanical name       - Semecarpus anacardium 
Family                    - Anacardiaceae 
Part used                - Seed 
Tast (suvai)           - Kaippu, viruviruppu 
Nature (thanmai) - Veppu 
Pirivu                   -   Kaarppu. 
Action: 
   Alterative 
    Caustic 
nghJ Fzk; : 
Nrhpuz;L Nrq;nfhl;il apbj; Jr;rhypy; 
n[yk;gjf;F tpl;lijAk; fye;J%B 
Chpaehs; nuz;ljd;gpd; thiyitj;J 
Cw;gdkh nahpj;Jtpby; jpuhtfj;ij 
rPuhf thq;fpapijf; Fg;gpapl;Lj; 
jpdq;nfhz;lhy; thjgpj;jnahpTNrhgk; 
ePupopT tapw;wpiur;ry; ePq;fhj;jhfk; 
epWj;Jnkd;W ahNfhg;G eprQ;nrhd;dhNu.              
Chemical Constituent: 
 Anacardic acid 
 Anacardol 
 Semecarpo 
 Catechol 
 Bhilawanol 
 Cardol 
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SERRANKOTTAI TREE 
SERRANKOTTAI 
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RESULTS AND OBSERVATION: 
 The factors considered for observation for the purpose of the study comprised of 
the following. 
 Age – Wise  
 Gender – wise classification  
 Distribution of thinai 
 Paruvakalam (seasonal incidence) 
 Occupation 
 Socio economic status  
 Dietary habits 
 Family history  
 Body weight  
 Classification of results according to Vali, Azhal & Iyam 
 Ezhu udal kattugal  
 Enn vagai thervugal  
 Classification on the basis of Neikuri  
 Naadi 
 Signs and symptoms  
 Urine                                                                                                                                                 
Fasting 
Post prandial 
 Blood Sugar  
    Fasting  
    Past prandial                                                    
 Glycosylated Hb (HbA1c) 
 Efficacy of medicine 
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TABLE – 1 
AGE WISE CLASSIFICATION: 
AGE NO OF PATIENTS PERCENTAGE 
30-39 3 Patients 7.5% 
40-49 13 Patients 32.5% 
50-59 13 Patients 32.5% 
60-69 9 Patients 22.5% 
70-79 2  Patients 5% 
 
 
 
 
 
 
It is observed from the above analysis that the incidence of Neerizhivu is more in 
the age group of 40-49, 50-59, and 60-69 in each of thes groups which clearly shows that 
Neerizhivu set automatically in the process of ageing ie.Pithakalam.   
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TABLE - 2 
GENDER WISE CLASSIFICATION 
 
GENDER NO OF PATIENTS PERCENTAGE 
Male 22 55% 
Female 18 45% 
 
 
 
 
 
 
From the pie chart the study done on the basis of patients who come for treatment 
of Neerzhivu at the hospital reveals that majority of them male are 55% and female 45% 
usually the NIDDM occurs both sexes.  
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TABLE - 3 
DISTRIBUTION OF THINAI 
THINAI NO OF PATIENTS PERCENTAGE 
Kurinchi - - 
Mullai - - 
Marutham 7 17.5% 
Neithal 33 82.5% 
Palai - - 
 
 
 
From the pie-chart as above it may be observed that people living in Neithal are 
prone to Neerizhivu while compared to others.This is very evident from the fact that 
82.5% of the patients with Neerizhivu are from this region. This indicates that the food 
habits of people in these regions which have a tropical climate and humid temperature 
play a signicant.    
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TABLE - 4 
SEASONAL INCIDENCE (PARUVA KAALAM) 
PARUVA KAALAM NO OF PATIENTS PERCENTAGE 
Kaar kaalam 
(Mid Aug to Mid Oct) 
1 2.5% 
Koothir kaalam 
(Mid Oct to Mid Dec) 
13 32.5% 
Munpani kaalam 
(Mid  Dec  to Mid Feb) 
3 7.5% 
Pinpani kaalam 
(Mid Feb to Mid Apr) 
3 7.5% 
Elavenil Kaalam 
(Mid Apr to Mid June) 
- - 
Muthuvenil kaalam 
(Mid June to Mid Aug) 
20 50% 
 
 
The chart clearly indicates that seasonal variations do not have a serious impact.In 
almost throughout the year Neerizhivu sets in. 
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TABLE – 5 
OCCUPATION: 
OCCUPATION NO OF PATIENTS PERCENTAGE 
Profossionals 13 32.5% 
Buissness 4 10% 
House wife 18 45% 
Labour 5 12.5% 
 
 
 
 
The chart it may be noted that the incidence of Neerizhivu is more on house wife 
i.e.45% of the total patients,32.5%on the office worker and 12.5% on the labor 
community.  
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TABLE – 6 
SOCIO ECONOMIC STATUS: 
 
INCOME  NO OF PATIENTS PERCENTAGE 
Low income group 
Below 10000/month 
5 12.5% 
Middle income group 
10000-20000/month 
20 50% 
High income group 
Above 20000/month 
15 37.5% 
 
 
 
 
         From the above table middle income group are prone to Neerizhivu. 
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TABLE – 7 
DIETARY HABITS: 
DIETARY HABITS NO OF PATIENTS PERCENTAGE 
Non-vegetarian 34 85% 
Vegetarian 6 15% 
 
 
 
 
 
 
        From the above table clearly shows that non- vegetarians people more prone to 
Neerizhivu.  
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TABLE – 8 
FAMILY HISTORY: 
FAMILY HISTIRY NO OF PATIENTS PERCENTAGE 
Father 8 20% 
Mother 10 25% 
No relevant History 22 55% 
 
 
 
 
 
 
 
        It is distinctly seen from the above table that no relevant history also plays an 
important role in Neerizhivu.  
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TABLE – 9 
BODY BUILD : 
WEIGHT NO OF PATIENTS PERCENTAGE 
Over weight 16 40% 
Normal weight 20 50% 
Lean 4 10% 
 
 
 
 
Shows that the role of normal weight people is more prone to Neerizhivu. 
The body mass index (BMI) in adult are derived from the formula, weight (Kg)/ 
height (m) 2.T-In overweight people the incidence of Neerizhivu is more he 
acceptable normal range of BMI is 20 to 25. 
The BMI between 25.0 to 29.9 are classified as overwigt.Obesity is taken to start at a                     
BMI of 30.0 to 39.9Davidsons Textbook of Medicine P.256 
 
 
   
 
0% 
5% 
10% 
15% 
20% 
25% 
30% 
35% 
40% 
45% 
50% 
Over weight Normal weight Lean 
40% 
50% 
10% 
Percentage 
Percentage 
92 
 
TABIL – 10 
 
VALI: 
 
 
 
 
 
           In Vali Abanan, Samanan, Viyanan are affected in all patients i.e. 100%. Koorman 
are affected 15% Kirukaran are affected in 90%, Devthathan are affected in 80% patients 
are affected. 
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S.NO PARTICULARS NO OF PATIENTS PERCENTAGE 
1 Pranan 0 0% 
2 Abanan 40 100% 
3 Udanan 0 0% 
4 Samanan 40 100% 
5 Viyanan 40 100% 
6 Nagan 0 0% 
7 Koorman 6 15% 
8 Kirukaran 36 90% 
9 Devathathan 32 80% 
10 Thananjayan 0 0% 
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                                                                   TABLE – 11 
AZHZL: 
 
 
 
 
 
         In Azhal: Anal pitham, Saathaga pitham are affected in 100% patients,Ranjaga 
pitham 10%, Alosaga pitham 20 % patients affected.   
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TABLE – 12 
IYAM: 
 
 
 
 
 
 
In Iyam: Kilethagam are affected in 100% patients and Santhigam 80% patients affected. 
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1 Avalambagam 0 0% 
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5 Santhigam 32 80% 
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TABLE – 13 
ENN VAGAI THERVUGAL – BEFORE TREATMENT: 
THERVUGAL NO OF PATIENTS PERCENTAGE 
Naa 40 100% 
Niram 4 10% 
Mozhi 0 0% 
Vizhi 6 15% 
Sparisam 14 35% 
Malam 12 30% 
Moothiram 40 100% 
 
 
 
 
 
On analyzing the facts of diagnosis, Naa, Moothiram had 100% impact.  
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TABLE – 14 
EZHU UDAL KATTTUGAL: 
EZHU UDAL KATTTUGAL NO OF PATIENTS PERCENTAGE 
Saaram 40 100% 
Seneer 40 100% 
Oon 6 15% 
Kozhuppu 6 15% 
Enbu 32 80% 
Moolai 0 0% 
Sukilam/Suronitham 0 0% 
 
 
 
 
From the above chart we can observe that Saaram and senner are affected in all 
patients i.e.100%.Kozhuppu, Oon are affected to the to the extended 15%%. Enbu are 
affected 80% respectively. 
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TABLE – 15 
CLASSIFICATION OF THE BASIS OF NEIKURI: 
 
NEIKURI NO OF PATIENTS  PERCENTAGE 
Kapa neer 20 50% 
Pitha neer 14 35% 
Vaatha neer 6 15% 
 
 
 
 
In respect of 50% of the patients when oil is dropped in the urine it look like 
Kapha Neer, In the balance 35% PithaNeer,which indicate kapham is prominent.  
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TABLE – 16 
NAADI: 
NAADI NO OF PATIENTS PERCENTAGE 
Pithavaatham 18 45% 
Vaathapitham 22 55% 
 
 
 
 
 
In 55% of the patients with Neerizhivu Vaatha pitham Naadi was prominent and 
45% of the cases Pitha vaatham was there. 
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TABLE – 17 
BEFORE AND AFTER TREATMENT OF SIGNS AND SYMPTOMS: 
SIGNS AND 
SYMPTOMS 
NO OF CASES 
BEFORE 
TREATMENT 
PERCENTAGE 
NO OF CASES 
AFTER 
TREATMENT 
PERCENTAGE 
Polyuria 40 100% 10 25% 
Polyphagia 40 100% 6 15% 
Polydipsia 40 100% 6 15% 
Balanitis or prunitis 
valvae 
0 0% 0 0% 
Itching all over the 
body 
14 35% 6 15% 
Dryness of the 
mouth and throat 
40 100% 2 5% 
Constipation 12 30% 0 0% 
Emaciation 14 35% 6 15% 
Peripheral neuritis 7 17.5% 0 0% 
Diabetic cataract 0 0% 0 0% 
Disturbed bed sleep 40 100% 4 10% 
 
 
In respect of the patients with Neerizhivu the clinical symptoms of polyurea, poly 
phagia, Dryness of mouth and throat, poly dipsia and disturbed sleep were present in all 
cases i.e 100% before treatment. 
The clinical signs and symtoms were improved after treatment showing only 25% 
of the have poly urea,15% of the people have polyphagia, 15% of the people have 
polydipsia,15% of the people have itching all over the body and 10%have disturbed sleep.  
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TABLE – 18 
URINE SUGAR - FASTING: 
 
URINE 
SUGAR - 
FASTING 
BEFORE 
TREATMENT 
PERCENTAGE 
AFTER 
TREATMENT 
PERCENTAGE 
++ 18 45% 0 0% 
+ 19 47.5% 10 25% 
NIL 3 7.5% 30 75% 
 
 
 
From the above chart it may be observed thst the Urine sugar position on fasting; 
after treatment had improved drastically it was nil in 75% of the cases after treatment. 
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TABLE – 19 
URINE SUGAR – POST PRANDIAL: 
URINE 
SUGAR – 
POST 
PRANDIAL 
BEFORE 
TREATMENT 
PERCENTAGE  AFTER 
TREATMENT 
PERCENTAGE 
+++ 21 52.5% 0 0% 
++ 15 37.5% 6 15% 
+ 4 10% 9 22.5% 
NIL 0 0% 25 62.5% 
 
 
 
 
It may be noted that the post prandial urine sugar position after treatment had 
improved drastically it was nil in 62.5% of the cases after treatment. 
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TABLE – 20 
BLOOD SUGAR – FASTING: 
 
BLOOD 
SUGAR – 
FASTING 
(mg) 
BEFORE 
TREATMEN
T 
PERCENTAG
E 
AFTER 
TRAETMEN
T 
PERCENTAG
E 
60-109 0 0% 29 72.5% 
110-149 19 47.5%            11 27.5% 
Above 150 21 52.5% 0 0% 
 
 
 
 
 
Fasting blood sugar has control in 72.5% of the cases. 
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TABLE – 21 
BLOOD SUGAR – POST PRANDIAL: 
BLOOD 
SUGAR – POST 
PRANDIAL(mg) 
BEFORE 
TREATMENT 
NO OF 
CASES 
PERCENTAGE 
AFTER 
TREATMENT 
PERCENTAGE 
100-149 0 0% 20 50% 
150-199 4 10% 14 35% 
200-249 15 37.5% 4 10% 
250 Above 21 52.5% 2 5% 
 
 
 
 
The blood sugar post prandial level has control 50% of the cases.  
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TABLE – 22 
 
ASSESSMENT OF HbA1c 
 
 
HbA1C 
 
BEFORE TREATMENT 
 
AFTER TREATMENT 
Good control 
5_7% 
0 0% 22 55% 
Fair control 
7_8% 
4 10% 10 25% 
Poor control 
Above 8% 
36 90% 8 20% 
 
 
 
 
The HbA1(C) results shows good control in 55% of the cases, fair control in 25% 
of the cases, poor control in 20% of the cases.  
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TABLE- 23  
 
OVER ALL PROGNOSIS 
S.NO PROGNOSIS PERCENTAGE 
1. Good control 55% 
2. Fair control 25% 
3. Poor control 20% 
 
 
 
 
INFERENCE: 
   Over all prognosis showed in 55% of cases. 
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DISCUSSION 
The open clinical trial on Neerizhivu was conducted at the OP/IP section of PG-Pothu 
maruthuvam department attached to Govt. A. A. H. OF INDIAN MEDICINE, 
CHENNAI-106 during the period 2011-2013.       
 
Neerizhivu was supposed to be associated with rich community of people of white 
collar job.But now a days the disease spread its wing to entire human kind.changing food 
habit life style and moderinization  of world plays vital role in the health aspect of 
humanity patient must be actively involved in his own management and should develop 
confidence to bring about adjustment in day to day management.A small group of 20 
patient in OPD and 20 patient in IP with complaints of Neerizhivu were selected. 
 
 The diagnosis was again established and confirmed with the help of envagai 
thervugal  and modern Bio chemical investigations these cases were given the trial drug 
with strict diet regimen.During the course of treatment the patient was subjected to 
routine blood sugar and urine sugar and blood pressure asscesments.         
AGE WISE ANALYSIS: 
It shows that the Neerizhivu common in the age 40-49-32.5%, 50-59-32.5%, 60-
69-22.5% ie.Pithakalam and usually the non insulin dependent diabetes mellitus occurs 
only in the middle and old aged groups. 
GENDER WISE: 
The gender wise classification shows that the Neerizhivu in the male 55%, Female 
45%, usually the non insulin dependent diabetes mellitus occurs both sexes equally. 
THINAI: 
95% of people living in Neithal are prone to Neerizhivu. The reason is that the 
land is closer to sea and food crops grown in that area is Alkaline.Also neithal land makes 
people obese which are one of the causes of Neerizhivu. 
 
SEASONAL INCIDENCE: 
There is no serious impact of seasonal variation in Neerizhivu.Muthuvenil kaalam 
50%, koothir kaalam 32.5%, munpani 7.5%, pinpani 7.5%, kaarkaalam 2.5% 
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OCCUPATION: 
Incidence of Neerizhivu is common  sedentary worker in female is more among 
housewife 45% due to modernization and invention of electrical electronic kitchen 
equipment and they lack physical exercise. In male it more among office workers 32.5%. 
 
SOCIO ECONOMIC STATUS: 
People belonging to all groups are affected by Neerizhivu.In olden  
Day it was said that rich community who lack exercise are prove to Neerizhivu.But recent 
research indicates that the poor were also prove to Neerizhivu. 
 
DIETARY HABITS: 
Non vegetarians are more prove to Neerizhivu.People who are habituated to fast 
food and jung food are more prove as they are rich in calories.   
 
FAMILY HISTORY: 
Family history has no relevant history in 55% of cases.It shows that though 
genetics play an important role in Neerizhivu. Non –Hereditary factors also plays an 
major role 
MUKKUTRAM CLASSSIFFICATION: 
IN VALI: 
Abanan, viyanan and samanan are affected. 
Action of Abanan: 
1. Regulation of excretion and feaces. 
2. Its derangement leads to polyuria and constipation. 
Action of viyanan: 
1. Exists all over the body lives in skin and active 72000 naadi. 
2. Helps in movement of all organs and sensation. 
3. In Neerizhivu viyanan is affects which leads to pain all over the body and 
peripheral neuritis. 
Action of samanan: 
1. Help in digestion and absorption of food. 
2. Strengthen the body. 
3. Samanan is affected in the turn metabolism of carbohydrate, protein and fat are 
affected. 
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IN AZHAL: 
Action of Analapitham: 
1. Action is exactly between the stomach and small intestine which means the 
pancreatic action is mainly maintained by Analapitham. 
2. It derangement causes Madhumegam. 
3. Analapitham is affected greatly in all patients.    
IN IYAM: 
1. The function of Kilethagam is to make the contents of the stomach ready for 
digestive process. 
2. If the function get deranged the initial phase of metabolism gets affected. 
3. Kilethagam affected in all patients.      
EZHU UDAL KATTUGAL 
1. In Neerizhivu saaram and seneer are affected in all patients.  
2. Affected saaram leads to emaciate and loss of interest in general activities. 
3. Decrese in saaram causes dryness of the skin and mouth. 
4. Affected seneer leads to nervousness, dryness, and paling and change in texture 
of the skin.       
ENN VAGAI THERVUGAL: 
-It shows Naa and Moothiram affected in100%, Vizhi affected in 15%. 
-Sparisam is affected in 35% which causes dry skin and peripheral neuritis. 
-Malam is affected in 30%, Niram is affected in 20%. 
NEIKURI: 
When oil is dropped in urine of the affected patient, it looks like pearl 50%0f 
cases,35% it spreads slowly and snake like 15%. 
NAADI: 
In all the patient pitha thondhanaadi is prominent. 
I.e. Vatha pitham 55%  
Pitha vatham 45% 
 
SIGNS AND SYMPTOMS: 
The main symptoms of Neerizhivu are polyurea; polyphagia and polydipsia are 
present in all cases. 
-It has marked improvement in all the above symptoms clinically and their 
condition was good. 
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Urine sugar fasting and urine sugar postprandial has become normal in 75% and 
62.5% of the cases respectively. 
Blood sugar fasting and post prandial has improved in 72.5% and 50% of the 
cases respectively. 
HbA1(C) - 5-7% in 55% of cases shows the valuable management and control of 
Neerizhivu. 
 
TREATMENT: 
MUKKUTRA THEORY 
 The treatment is based on the derangement of Mukkutram which again is based on 
the panchabootham theory.  
 Incidence of Neeerizhivu and treatment are also based on these primary principles 
of siddha medicine. 
 The fusion of Neer and Mann gives raise to sweetness.If there is excess of these 
boothas in the body.It is excreted in the urine, which gives sweetness to urine that 
is Neerizhivu iyam is primarily dearranged. 
 The fusion of Thee +Thee gives raise to pitham,excess of these boothas in the 
body,it is excreted in the urine, dryness of mouth and derangemend of Sukkilam 
and suronitham. 
 The Medicine chosen to treat Neerizhivu kaippu suvai (Kattru+vinn) which has 
the property to control Polyurea and excess of fat and balance pitha kutram and 
kaba kutram.According to the above concept the drug act on the –rinciple of 
Ethirurai. 
 The trial medicine chosen to treat Neerizhivu has Kaippu suvai which is used 
settle down the pitha kuttrum there by the drug plays an important role on 
Neerizhivu. 
 The drug also subjected to pharmacological and toxicological tests in rat 
models.The results revealed that the Seeronkottai thiravagam had very effective 
results and no toxicity was absorbed during the toxicity study. 
 The biostatistical report of the clinical trial shows significant result.      
    
 
 
110 
 
SUMMARY 
 
  Yugi munivar classified megarogam into 20 varieties in which Neerizhivu  is one 
among them.Disease  Neerizhivu come under pitha neer classification which is very 
specific and correlates with maturity onset diabetes mellitus i.e.non insulin 
dependent,which is a chronic metabolic disorder.Currently Neerizhivu is considered as 
one of the worst life style disorders faced by civilized world. 
The clinical diagnosis of all the cases of Neerizhivu were done on basis of signs 
and symptoms explained by yugi in siddha text yugi vaidhya  chinthamani -800,Noi 
Naadal and Noi muthal Naadal  and modern concept whereas need.  
The disease Neerizhivu has been thoroughly studied by selecting totally 40 
patients were treated both OP & IP Department of pothu maruthuvam, Arignar Anna 
Hospital for period of 2 years. 
Patients were examind and investigated with Siddha and Modern concept. 
The medicine administered were, 
 Seerankottai thiravagam -10 drops with water twice daily after food. 
 Encouragingly the patients responded to the medicine showing gradual decrease 
in signs and symptoms. 
 No hypoglycemia was observed during the study. 
 HbA1(c) - 5% to 7% in 55% of cases shows the valuable management and control 
of Neerizhivu. 
 Seeronkottai thiravagam also significantly prevents associated symptoms like 
high bood pressure peripheral neuritis, cholesterol in the blood. 
 The drug shows no contra indications and side effect. 
 The drug also subjected to Pharmacological and toxicological tests in rat models. 
The result revealed that the Seeronkottai thiravagam had very effective result. 
There were no signs of toxicity as could be judged by the absence of undesirable 
clinical manifestations. 
 The biostatistical report of the clinical trial shows significant result.      
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            CONCLUSION 
 
 The drugs selected in this study are very effective and easily available. 
 Rasam (mercury) is very specific in treating Megarogam. The drug Seeronkottai is 
equal to rasam in the action, so this drug specifically treats Neerizhivu. 
 The drug acts as Kayakarpam. 
 Route of administration is easy. 
 As the drug is in Thiravagam from absorption is very quick. 
 The drug is a safe and effective one for Neerizhivu. 
 The drug has anti-hyperglycemia activity in rat model. 
 The drug is economically viable and without any untoward side effect. 
 The drug used to prepare the medicine is easily available herb, which even helps 
the lay man support from this disease. 
 The pharmacological study revealed that the Seerankottai thiravagam yield ed 
good results in rat models. 
 The statistical analysis proved significance of clinical improvement with the 
treatment. 
 As the result of this dissertation work is highly encouraging and the medicine 
being a cost effective one for the treatment of NEERIZHIVU, further detailed 
study will definitely fruitful to the society.   
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ANNEXURE –I 
CHEMICAL ANALYSIS OF TRIAL MEDICINES 
 
Preparation of Sodium Carbonate extract: 2 gm of the sample is mixed 5 gm of 
Sodium carbonate and taken in a 100 ml beaker and 20 ml of distilled water is added.  
The solution is boiled for 10 minutes, cooled and then filtered.  The filtrate is called 
sodium carbonate extract. 
 
S.No. 
 
Experiment 
Inference 
Drug Drug 
1 Test for Acid Radicals   
a. Test for Sulphate 
2 ml of the above prepared extract 
is taken in a test tube.  To this add 
2ml of 4% Ammonium oxalate 
solution. 
Absence of              
White  Precipitate 
Absent 
b. 2ml of extract is added with 2ml of 
dilute hydrochloric acid until the 
effervescence ceases off.  Then 
2ml barium chloride solution is 
added. 
Absence of              
White  Precipitate 
Absent 
2. Test for Chloride: 
2ml of extract is added with dilute 
nitric acid till the effervescence 
ceases.  Then 2ml of silver nitrate 
solution is added. 
 
white precipitate is 
obtained. 
 
Present 
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3. Test for Phosphate 
2ml of the extract is treated with 2 ml of 
Ammonium molybdate solution and 2ml of 
concentrated nitric acid. 
Yellow Precipitate 
is obtained. 
Absent 
4. Test for Carbonate: 
2ml of the extract is treated with 2ml of 
magnesium sulphate solution. 
Absence of white 
precipitate 
Absent 
5. Test for Sulphide: 
1 gm of the substance is treated with 2ml of 
concentrated Hydrochloric acid 
Absence of Rotten 
egg smelling 
Absent 
6. Test for Nitrate: 
1gm of the substance is heated with copper 
turnings and concentrated sulphuric acid and 
viewed the test tube vertically down. 
Absence of reddish 
brown gas. 
Absent 
7. 
a. 
Test for Fluoride and oxalate 
2ml of the extract is added with 2ml of dilute 
acetic acid and 2ml of calcium chloride 
solution and heated. 
Absence of white 
precipitate 
Absent 
b. 5 drops of clear solution is added with 2ml of 
dilute sulphuric acid and slightly warmed to 
this, 1 ml of dilute potassium permanganate 
solution is added. 
Absence of 
KMNO4 solution 
discolourisation. 
Absent 
8. Test for Nitrite 
3 drops of the extract is placed on a filter 
paper.  On that, 2 drops a Acetic Acid and 2 
drops of Benzidine solution is placed. 
Absence of 
yellowish red 
colour 
Absent 
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9. Test for Borate 
2 pinches of the substance is made into paste 
by using Sulphuric acid and Alcohol (95%) 
and introduced into the blue flame. 
Absence of Green 
tinged flame 
Absent 
II. TEST FOR BASIC RADICALS  
10. Test for lead 
2 ml of the extract is added with 2 ml of 
Potassium iodide solution 
Absence of Yellow 
precipitate 
Absent 
11a Test for Copper 
One pinch of substance is made into paste with 
concentrated Hydrochloric acid in a watch 
glass and introduced into the non luminous 
part of the flame. 
Absence of bluish 
green coloured 
flame 
Absent 
b. 2ml of the extract is added with excess of 
Ammonia solution 
Absence of deep 
blue 
Absent 
12. Test for Aluminium 
To the 2 ml of extract.  Sodium Hydroxide 
solution is added in drops to excess. 
Absence of     
White precipitate. 
Absent 
13a Test for Iron 
To the 2 ml of extract, 2 ml of Ammonium 
Thiocyanate solution is added. 
Absence of     
Blood red colour. 
Absent 
b. To the 2 ml of extract, 2 ml of Ammonium 
Thiocyanate solution and 2 ml of concentrated 
Nitric Acid is added. 
Absence of     
Blood red colour 
Absent 
14. Test for Zinc 
To the 2 ml of extract Sodium Hydroxide 
solution is added in drops to excess. 
Absence of     
White precipitate 
Absent 
15. Test for Calcium 
2 ml of the extract is added with 2 ml of 4% 
Ammonium Oxalate solution. 
Absence of      
White precipitate. 
Absent 
16. Test for Magnesium 
2ml of extract, Sodium Hydroxide solution is 
added in drops to excess. 
Absence of   White 
precipitate. 
Absent 
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17. Test for Ammonium 
2 ml of extract few ml of Nessler’s Reagent 
and excess of Sodium Hydroxide solution are 
added. 
Absence of   
Reddish brown 
precipitate 
Absent 
18. Test for Potassium 
A pinch of substance is treated with 2 ml of 
Sodium Nitrite solution and then treated with 2 
ml of Cobal Nitrate in 30% glacial Acetic acid. 
Absence of Yellow 
precipitate 
Absent 
19. Test for Sodium 
2 pinches of the substance is made into paste 
by using Hydrochloric acid and introduced 
into the blue flame. 
Absence of Yellow 
colour flame 
Absent 
20. Test for Mercury 
2 ml of the extract is treated with 2 ml of 
Sodium Hydroxide solution. 
Absence of yellow 
precipitate 
Absent 
21. Test for Arsenic 
2 ml of extract is treated with 2 ml of silver 
Nitrate solution 
Absence of                                                                                                                    
Yellow precipitate. 
Absent
22. Test for Starch 
2ml of extract is treated with weak iodine 
solution 
Absence of                                                                                                                    
Blue colour 
Absent
23. Test of reducing Sugar 
5ml of Benedict’s qualitative solution is taken 
in a test tube and allowed to boil for 2 minutes 
and added 10 drops of the extract and again 
boiled for 2 minutes.  The colour changes are 
noted. 
Green colour is 
obtained. 
Present 
24. Test of  the alkaliods  2ml of the extract is 
treated with  2ml of potassium iodide solution 
Absence of Red 
colour 
Absent 
 
 
25. Test for proteins: (biuret test) Take 2 ml of 
solution and 2ml of 5% sodium hydroxide, 
mix and add 2 drops of copper sulphate.  
violet colour is 
obtained 
present 
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RESULTS 
 
 The given sample contains. 
 
 Drug- serrankottai thiravagam– 2ml 
 
 Chemicals present: 
 
 Chloride 
 
 Reducing sugar 
 
 Protein. 
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ANNEXURE.-II 
ACUTE AND SUB ACUTE TOXICITY STUDY ON SERANKOTTAI 
THIRAVAGAM 
Animals  
Mice of either sex weighing 25-30g and rats weighing 210-240g were obtained 
from the animal house and those animals were used with the approval of the Institute 
animal ethics committee and obtained from Vels University, Chennai. They were fed with 
a balanced standard pellet diet and maintained under standard laboratory conditions, 
providing 24-28
0
C temperature, standard light cycle (12 h light, 12 h dark) and water ad 
libitum. Animals were kept in cages with raised floors of wide mesh to prevent 
coprophagy. Animal welfare guidelines were observed during the maintenance period and 
experimentation. The rats were randomly assigned to control and different treatment 
groups, six animals per group. The animals were acclimatized for one week under 
laboratory conditions.  
ACUTE TOXICITY STUDY-OECD 425 GUIDELINES 
Acute oral toxicity test for the Serankottai Thiravagam was carried out as per 
OECD Guidelines 425. As with other sequential test designs, care was taken to ensure 
that animals are available in the appropriate size and age range for the entire study. The 
test substance is administered in a single dose by gavage using a stomach tube or a 
suitable intubation cannula. The fasted body weight of each animal is determined and the 
dose is calculated according to the body weight. After the substance has been 
administered, food was withheld for a further 2 hours in mice. The animals were observed 
continuously for the first 4 h and then each hour for the next 24 h and at 6 hourly intervals 
for the following 48 h after administering of the test drug, to observe any death or 
changes in general behaviour and other physiological activities. Single animals are dosed 
in sequence usually at 48 h intervals. However, the time interval between dosing is 
determined by the onset, duration, and severity of toxic signs. Treatment of an animal at 
the next dose was delayed until one is confident of survival of the previously dosed 
animal.  
Observation of toxicity signs: General behavior, respiratory pattern, cardiovascular signs, 
motor activities, reflexes, change in skin and fur, mortality and the body weight changes 
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were monitored daily. The time of onset, intensity, and duration of these signs, if any, was 
recorded.  
SUB-ACUTE TOXICITY  
 In a 28-days sub acute toxicity study, twenty four rats were divided into four 
groups of 6 rats each. Group I that served as normal control was administered with 
distilled water (p.o.) while groups II, III and IV were administered daily with the 
Serankottai Thiravagam (p.o.) for 28 days at a dose of 0.5, 1.0 and 1.5ml/kg respectively. 
The animals were then observed daily for gross behavioural changes and any other signs 
of subacute toxicity. The weight of each rat was recorded on day 0 and weekly throughout 
the course of the study, food and water consumption per rat was calculated. At the end of 
the 28 days they were fasted overnight, each animal was anaesthetized with diethylether, 
following which they were then dissected and blood samples were obtained by cardiac 
puncture into heparinised tubes. The blood sample collected from each rat was 
centrifuged with 3000 X g at 4
o
C for 10 min to separate the serum and used for the 
biochemical assays.  
Hematological and blood biochemical analyses:  
At the end of the study, all animals were kept fasted for 16-18 h and then 
anesthetized with anesthetic ether on the 28th day. Blood samples for hematological and 
blood chemical analyses were taken from retro orbital vein. Heparinized blood samples 
were taken for determining complete blood count (white blood cell count, differential 
white blood cell count, platelet count, red blood cell count, hematocrit, and hemoglobin) 
by semiautomated hematology analyzer. The serum from non-heparinized blood was 
carefully collected for blood chemistry and enzyme analysis glucose, creatinine, total 
protein, albumin, total and direct bilirubins, serum glutamate-oxaloacetate transaminase 
(SGOT), serum glutamate pyruvate transaminase (SGPT), and alkaline phosphatase 
(ALP)) were automatically determined using autoanalyzer. 
Necropsy:  
All rats were sacrificed after the blood collection. The positions, shapes, sizes and 
colors of internal organs were evaluated. The Spleen, Testes, Pancrea, Lung, Liver, Brain, 
Heart, Stomach, Intestine, Bone, Ovary, and Kidney tissues were excised from all rats to 
visually detect gross lesions, and weighed to determine relative organs’ weights and 
preserved in 10% neutral formalin for histopathological assessment. The tissues were 
embedded in paraffin, and then sectioned, stained with haematoxylin and eosin and were 
examined microscopically. 
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Statistical analysis 
Values were represented as mean ± SEM. Data were analysed using one-way 
analysis of variance (ANOVA) and group means were compared using the Tukey-Kramer 
Multiple Comparison test using GraphPad Instat-V3 software. P<0.05 were considered 
significant. 
RESULTS 
Animals treated with Serankottai Thiravagam 1ml/kg onwards shown significant 
toxic clinical signs during the dosing period of 28 days. All animals from control and all 
the treated dose groups not survived throughout the dosing period of 28 days and it was 
found four animal dead after 12days of treatment in moderate and high dose. Results of 
body weight determination of animals of control and different dose groups exhibited body 
weight loss throughout the dosing period of 28 days. During dosing period, the quantity 
of food consumed by animals from different dose groups was found to be comparable and 
normal with that of control animals.  
 Ophthalmoscopic examination of animals in control and Serankottai Thiravagam 
treated group revealed remarkable abnormality in liver and kidney. Urine analysis data of 
control group and treated group of animals determined in week 4 did not reveal any 
significant abnormalities except pH changes. Comparison of organ weights of treated 
animals with respective control animals on day 28 was found to be altered. Gross 
pathological examination of animals in the Serankottai Thiravagam treated group 
revealed abnormalities.  
 The results of haematological investigations conducted on day 28, revealed 
changes in the values of different parameters investigated when compared with those of 
respective controls; Results of Biochemical investigations revealed the few significant 
changes in the values of different parameters studied when compared with those of 
respective controls; however, the values obtained were within biological and laboratory 
limits. 
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Table 1: Dose finding experiment and its behavioral Signs of Toxicity 
Dose 
ml/k
g 
1 2 3 4 5 6 7 8 9 
1
0 
1
1 
1
2 
1
3 
1
4 
1
5 
1
6 
1
7 
1
8 
1
9 
2
0 
1 + + - + - + - + + + - - - + + + + + + + 
2 + + - + - + - + + + - - - + + + + + + + 
 
1. Alertness 2. Aggressiveness 3. Pile erection 4. Grooming 5. Gripping 6. Touch 
Response 7. Decreased Motor Activity 8. Tremors 9.  
2. Convulsions 10. Muscle Spasm 11. Catatonia 12. Muscle relaxant 13. Hypnosis 
14. Analgesia 15.Lacrimation 16. Exophthalmos 17. Diarrhoea 18. Writhing 19. 
Respiration 20. Mortality 
 
Table 2. Body wt (g) of rats exposed to Serankottai Thiravagam for 28days. 
 
Dose 
(ml/kg/day) 
Days 
1 7 14 21 28 
Control 141.595.19 146.345.00 148.264.96 153.685.42 162.226.12* 
0.5 152.254.87 154.024.33 156.225.00 141.124.56 134.614.51* 
1 155.145.00 157.675.10 155.094.24 143.564.88 132.255.02** 
1.5 144.425.36 146.284.42 142.314.20 136.624.75 130.184.99 
 
Values are mean  S.E.M. (Dunnet ’t' test). *P>0.05; **P>0.01. N=6. 
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Table 3. Food intake of rats exposed to Serankottai Thiravagam for 28days. 
 
Dose 
(ml/kg/day) 
Days (gms/rats) 
1 7 14 21 28 
Control 42.752.85 44.332.95 47.152.55 46.242.20 48.263.21 
0.5 40.222.46 45.522.61 41.262.67 40.512.15 41.523.00 
1 42.442.25 45.502.46 42.442.26 40.222.43 40.442.82 
1.5 42.382.16 45.142.34 40.522.79 38.122.45 45.222.61 
Values are mean  S.E.M. (Dunnet ’t' test). nsP>0.05. N=6. 
 
Table 4. Water intake of rats exposed to Serankottai Thiravagam for 28days. 
 
Dose 
(ml/kg/day) 
Days(ml/rat) 
1 7 14 21 28 
Control 40.002.45 48.222.52 45.603.36 51.202.18* 52.103.22* 
0.5 42.252.28 46.042.67 52.413.00* 48.222.80 52.312.74* 
1 41.962.24 47.183.00 52.622.88* 50.122.66 50.853.00 
1.5 45.202.25 51.343.28 54.122.54 56.002.54* 54.122.64 
Values are mean  S.E.M. (Dunnet ’t' test). *P<0.05.. N=6. 
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Table 5. Hematological parameters after 28days treatment with Serankottai 
Thiravagam. 
Parameter Control 0.5ml/kg 1ml/kg 1.5ml/kg 
Red blood cell 
(mm
3
) 
5.100.42 5.570.48 5.120.36 5.180.40 
HB (%) 16.480.36 15.810.45 14.220.34** 15.120.31* 
Leukocyte 
(x10
3
/Cu.mm) 
8.001.4 8.241.12 8.000.94 7.161.52 
Platelets(K/µl) 42614.11 45117.00 41218.33 42420.24 
MCV (gl) 54.334.15 54.544.24 54.004.12 54.024.18 
Neutrophil 15.171.08 15.370.88 15.180.74 15.263.42 
Lymphocyte 76.242.46 78.022.19 80.102.15 82.002.92 
Monocyte 1.320.28 1.410.30 1.370.21 1.660.32 
Eosinophil 1.000.12 2.020.11** 2.000.10** 3.140.12** 
Basophil 00.00 10.01** 20.01** 10.01** 
ESR(mm) 100 20.01** 30.02** 40.04** 
PCV 52.662.74 52.142.45 54.183.00 53.103.05 
Values are mean  S.E.M. (Dunnet ’t' test). *P<0.05; **P<0.01. N=6. 
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Table 6. Effect of treatment with Serankottai Thiravagam biochemical parameters 
Dose (mg/kg) Control 0.5ml/kg 1ml/kg 1.5ml/kg 
Total Bilirubin 
(mg/dL) 
0.280.02 0.300.04 0.300.03 0.320.04 
Bilirubin direct 
(mg/dL) 
0.250.04 0.220.03 0.250.04 0.260.05 
ALP (U/L) 104.854.56 114.204.78 110.154.22 112.255.00 
SGOT (U/L) 110.184.33 112.544.41 117.205.12 112.225.44 
SGPT(U/L) 34.112.52 34.172.46 34.442.95 35.102.43 
Total Protein(g/dl) 7.301.48 6.881.00 7.310.90 7.100.84 
Albumin(g/dl) 2.430.22 2.350.31 2.820.24 3.000.25 
Globulin(g/dl) 5.000.28 5.150.42 5.000.36 4.720.32 
Values are mean  S.E.M. (Dunnet ’t' test). nsP>0.05 Vs Control N=6. 
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Table-7 RFT 
Dose (mg/kg) Control 0.5ml/kg 1ml/kg 1.5ml/kg 
Urea (mg/dL) 4.521.48 4.441.30 5.001.85 4.961.64 
Creatinine (mg/dL) 0.700.04 0.700.05 0.780.05 0.820.05 
Uric acid (mg/dL) 3.740.15 5.130.18** 4.550.12** 6.120.14** 
Na m.mol 114.125.00 115.024.78 115.894.70 112.643.99 
K m.mol 6.422.41 6.251.44 6.521.23 6.342.11 
Cl m.mol 104.14.00 106.204.64 105.484.75 104.445.00 
Values are mean  S.E.M. *P<0.05; **P<0.01. Vs. Control N=6. 
 
Table-8. Lipid Profile 
Dose (mg/kg) Control 0.5ml/kg 1ml/kg 1.5ml/kg 
Total cholestrol(mg/dL) 76.115.78 73.045.42 70.266.20 66.214.82 
HDL(mg/dL) 38.514.10 34.184.56 36.245.00 32.122.78 
LDL(mg/dL) 41.004.12 42.413.38 36.202.58 40.454.77 
VLDL(mg/dl) 24.182.55 25.422.41 24.282.44 24.822.64 
Triglycerides (mg/dl) 24.102.00 25.122.15 25.052.84 25.142.45 
Blood glucose(mg/dl) 76.884.45 81.223.88 72.424.00 69.784.45 
Values are mean  S.E.M. (Dunnet ’t' test). nsP>0.01 Vs Control N=6. 
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Table-9 Urine Analysis 
Parameters Control 0.5ml/kg 1ml/kg 1.5ml/kg 
Colour Yellow Yellow Brown
 
Brown 
Transparency Clear turbid cloudy Turbid 
Specific gravity 1.010 1.010 1.010 1.010 
PH >7.2 >8.2 >8.2 >8.4 
Protein Nil 1+ 2+ 2+ 
Glucose Nil Nil Nil Nil 
Bilirubin -ve -ve -ve +ve 
Ketones -ve -ve +ve +ve 
Blood Absent Absent Absent Absent 
Urobilinogen Normal Normal Normal Normal 
Pus cells 0-cells/HPF 1-cell/HPF 2-cells/HPF 1-cell/HPF 
RBCs Nil Nil 0-1cells/HPF Nil 
Epithelial cells Nil 1-cell/HPF Nil 1-cell/HPF 
Crystals Nil Nil Nil Nil 
Casts Nil Nil Nil Nil 
Others Bacteria seen Bacteria seen Bacteria seen Bacteria seen 
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Table 10. Effect of Serankottai Thiravagam on organ weight 
Dose (mg/kg) Control 0.5ml/kg 1ml/kg 1.5ml/kg 
Liver (g) 3.000.10 3.100.12 2.920.09 2.580.10* 
Heart (g) 0.300.04 0.300.04 0.290.02 0.300.02 
Lung (g) 0.440.12 0.440.10 0.450.10 0.440.12 
Spleen (g) 0.450.04 0.460.04 0.460.05 0.470.04 
Ovary (g) 1.620.28 1.640.20 1.660.18 1.640.21 
Testes (g) 2.320.12 2.340.11 2.300.10 2.330.12 
Brain (g) 1.220.14 2.200.12** 2.200.12** 2.100.10** 
Kidney (g) 0.810.05 0.780.05 0.750.05 0.720.04 
Stomach (g) 1.120.11 1.140.12 1.100.10 1.120.11 
Values are mean  S.E.M. (Dunnet ’t' test). *P<0.05; **P<0.01 Vs Control. N=6. 
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SUBACUTE TOXICITY OF SEERONKOTTAI THIRAVAGAM 
BRAIN 
                            HIGH DOSE               LOW DOSE                 MID DOSE  
                                               
HEART  
HIGH DOSE               LOW DOSE                 MID DOSE 
                                               
 
INTESTINE 
                        HIGH DOSE             LOW DOSE                  MID DOSE  
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SUBACUTE TOXICITY OF SEERONKOTTAI THIRAVAGAM 
KIDNEY  
    HIGH DOSE               LOW DOSE          MID DOSE 
                                               
LIVER  
HIGH DOSE               LOW DOSE          MID DOSE 
                                              
 
LUNGS  
HIGH DOSE               LOW DOSE          MID DOSE 
                                             
:  
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SUBACUTE TOXICITY OF SEERONKOTTAI THIRAVAGAM 
OVARY 
HIGH DOSE               LOW DOSE          MID DOSE 
                                               
PANCREAS 
HIGH DOSE               LOW DOSE          MID DOSE 
                                               
 
          SPLEEN  
HIGH DOSE               LOW DOSE          MID DOSSE 
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SUBACUTE TOXICITY OF SEERONKOTTAI THIRAVAGAM 
STOMACH 
HIGH DOSE               LOW DOSE          MID DOSE 
                                               
TESTIS 
HIGH DOSE               LOW DOSE          MID DOSE 
                                              
 
          BONE  
                        HIGH DOSE               LOW DOSE          MID DOSE  
                                               
 
 
 
 
132 
 
ANNEXURE-III 
 
ANTIDIABETIC ACTIVITY OF SERANKOTTAI THIRAVAGAM IN ALLOXAN 
INDUCED DIABETIC RATS 
INTRODUCTION: 
 
 Diabetes mellitus consists of a group of syndromes characterized by 
hyperglycemia; altered metabolism of lipids, carbohydrates, and proteins; and an 
increased risk of complications from vascular disease. Apart from currently available 
therapeutic options for diabetes like oral hypoglycemic agents and insulin. Nowadays, 
many Indian systems of medicines have been recommended for the treatment of diabetes. 
Diabetes mellitus occurs throughout the world; however, it is more common in the more 
developed countries. Diabetes is in the top 10, perhaps in the top 5, of the most significant 
diseases in the developed world and is still gaining significance. Therefore, it is advised 
to allow such remedial measures as supplements to other modes of therapy. Alloxan 
causes diabetes through its ability to destroy the insulin-producing beta cells of the 
pancreas. In vitro studies have shown that alloxan is selectively toxic to pancreatic beta 
cells, leading to the induction of cell necrosis. The cytotoxic action of alloxan is mediated 
by reactive oxygen species, with a simultaneous massive increase in cytosolic calcium 
concentration, leading to a rapid destruction of beta cells. The objective of our present 
study is to prove the antidiabetic activity of the Serankottai Thiravagam by using alloxan 
induced diabetic rats. 
 
MATERIALS AND METHODS 
 
Animals 
 Wistar albino rats (8–10 weeks) of both sexes were obtained from the animal 
house of School of Pharmacy, Vels University, Chennai. Before and during the 
experiment, rats were fed with standard diet (Sai durga foods, Bangalore). After 
randomization into various groups and before initiation of experiment, the rats were 
acclimatized for a period of 7 days under standard environmental conditions of 
temperature, relative humidity, and dark/light cycle. Animals described as fasting were 
deprived of food and water for 16 hours ad libitum. The present study was conducted 
133 
 
after getting experimental protocol approval from Institutional 
AnimalEthicsCommittee(IAEC).(No. 
XIII/VELS/PCOL/06/2000/CPCSEA/IAEC/08.08.2012) 
Drugs, Chemicals and stock solution 
 Alloxan (Loba chemie, Mumbai, India), and diagnostic kits (Biolab diagnostics, 
Mumbai, India) were used in this study. Other chemicals used were of analytical grade 
and were obtained from local suppliers. The drug Serankottai Thiravagam was diluted 
with saline. The drug was administered continuously for 21 days orally using an oral 
feeding tube. The results were compared with that of the standard drug Glibenclamide 
which was also given continuously for 21 days. 
Oral Glucose Tolerance Test 
 Rats were divided into five groups containing six animals in each group. All 
animals fasted before treatment. Group I was kept as vehicle control which received only 
saline p.o., group II received glucose only (2g/kg, p.o.), group III received Serankottai 
Thiravagam 1ml/kg, and group IV received Serankottai Thiravagam 2ml/kg. The rats of 
group V were treated with Glibenclamide. Blood samples were collected by puncturing 
the retro orbital sinus just prior to drug administration, and 30, 90 minutes after loading 
glucose. Serum glucose level was measured immediately.  
 
Acute Oral Toxicity Studies 
 Acute oral toxicity study was performed as per OECD-425 guidelines. Mice (n = 
6) of either sex selected by random sampling technique were used for acute toxicity 
study. The animals were kept fasting for overnight providing only water, after which the 
Serankottai Thiravagam in normal saline was administered orally at the different dose 
levels in up and down dosing schedule according to body weight by gastric intubation and 
observed for 14 days.  
Experimental Design 
Five groups of rats, six in each received the following treatment schedule. 
Group I: Normal control (saline). 
Group II: Alloxan treated control (150mg/kg.ip). 
Group III: Alloxan (150mg/kg.i.p) + Serankottai Thiravagam 1ml/kg, p.o, 
Group IV: Alloxan (150mg/kg.ip) + Serankottai Thiravagam 2ml/kg, p.o 
Group V: Alloxan (150mg/kg.ip) + Standard drug, Glibenclamide (5mg/kg, p.o). 
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 Serankottai Thiravagam and standard drug glibenclamide (5mg/kg) and saline 
were administered with the help of feeding cannula. Group I serve as normal control, 
which received saline for 14 days. Group II to Group V are diabetic control rats. Group 
III to Group V (which previously received alloxan) are given a fixed dose Serankottai 
Thiravagam (1ml/kg, p.o), (2ml/kg, p.o) and standard drug glibenclamide (5mg/kg) for 14 
consecutive days. 
Induction of Diabetes in Experimental Animals 
 Rats were made diabetic by a single intraperitoneal injection of alloxan 
monohydrate (150mg/kg). Alloxan was first weighed individually for each animal 
according to the body weight and then solubilized with 0.2ml saline just prior to injection. 
Two days after alloxan injection, rats with plasma glucose levels of >150mg/dl were 
included in the study. Treatment with Serankottai Thiravagam was started 48 h after 
alloxan injection. 
 
Collection of Blood Sample and Blood Glucose Determination 
 Blood samples were drawn from tail tip of rat at weekly intervals till the end of 
study. Fasting blood glucose estimation and body weight measurement were done on day 
1, 7, and 14 of the study. Blood glucose estimation was done by one touch electronic 
glucometer using glucose test strips. On day 14, blood was collected from retro-orbital 
plexus under mild ether anesthesia from overnight fasted rats and fasting blood sugar was 
estimated.  
 Serum was separated and analyzed for serum cholesterol, serum triglycerides, 
serum HDL, serum LDL was estimated. The whole pancreas from each animal was 
removed after sacrificing the animal and was collected in 10% formalin solution, and 
immediately processed by the paraffin technique. Sections of 5μ thickness were cut and 
stained by haematoxylin and eosin for histological examination. 
 
Statistical Analysis 
 All the values of body weight, fasting blood sugar, and biochemical estimations 
were expressed as mean ± standard error of mean (S.E.M.) and analyzed for ANOVA and 
Dunnet's t-test. Differences between groups were considered significant at P <0.01. 
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RESULTS AND DISCUSSION 
 The OECD guidelines AOT-425 was followed for estimation of acute toxicity 
Study in mice. Mortality in the acute oral toxicity test was seen in the dose 2ml/kg. The 
animals showed severe toxic signs and abnormal behavior like itching, restlessness and 
aggressiveness etc. Hence, as per the siddha literature recommendations the main stock 
was further diluted ten times with saline and from this diluted stock solution 1ml and 
2ml/kg dose was considered for the further pharmacological evaluation. To ascertain a 
scientific base for the usefulness of this drug in the treatment of diabetes, it was decided 
to evaluate experimental design of antidiabetic activity by following glucose tolerance 
test and the alloxan-induced model.  
 After alloxon administration, there was severe hyperglycemia in all the animals 
when compared with the normal animals. The upper bound dose 2ml/kg doses of 
Serankottai Thiravagam significantly lowered the elevated blood glucose level when 
compared with that of diabetic control. It was observed that the standard drug 
glibenclamide lowered the blood glucose level significantly bringing it nearly back to 
normal, whereas Serankottai Thiravagam significantly (P<0.05) decreased fasting blood 
serum glucose in the diabetic rats after five days of treatment compared with the initial 
blood serum glucose levels. However, the sugar control effect of the Serankottai 
Thiravagam was incomparable to that of the reference drug. In the present investigation, 
statistical analysis revealed that the 21 days treatment with standard drug Glibenclamide 
showed significant decrease in glucose, cholesterol, triglyceride VLDL, LDL and 
increase in body weight and HDL level, thereby exhibited significant antidiabetic activity. 
 Alloxan, a beta cytotoxin, induces ‘chemical diabetes’ in a wide variety of animal 
species by damaging the insulin-secreting cells of the pancreas. Though not routinely 
used anymore, the oral glucose tolerance test is the gold standard for making the 
diagnosis of type 2 diabetes. It is still commonly used for diagnosing gestational diabetes 
also. Literature sources indicate that alloxan treated rats are hyperglycemic. The use of 
alloxan (150 mg/kg b.w.) produced a partial destruction of pancreatic β-cells even though 
the animals became permanently diabetic. Thus, these animals have surviving β -cells and 
regeneration is possible. The acute oral toxicity study of Serankottai Thiravagam showed 
mortality at 2ml/kg. Since the Serankottai Thiravagam was identified with remarkable 
toxicity at the higher dose in the acute toxicity study. Hence the stability and tolerance 
was observed at 0.2ml/kg dose level.  Administration of diabetogenic agent alloxan 
150mg/kg, i.p. lead to elevation of fasting blood glucose levels, which was maintained 
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over a period of 2 weeks. Alloxan caused body weight reduction (P<0.01), which is 
reversed by Serankottai Thiravagam at the dose (2ml/kg) is more effectively after 5days 
of treatment.  
 The control rats had the blood glucose level 74.52 ± 2.42mg/dl while untreated 
diabetic rats showed 215.72±10.14mg/dl blood glucose level. On day 5, 10 and 14 of 
treatment at 2ml dose of Serankottai Thiravagam reduced the blood glucose level to 
184.40±10.26, 172.14±8.65 and 158.00±9.00mg/dl (P<0.01) respectively. In present 
investigation, it was observed that Serankottai Thiravagam can reverse the effects of 
Alloxan induced diabetes to a significant level.  
Histopathological changes in pancreas 
Normal - Normal acini and normal cellular population in the islets of Langerhans in 
pancreas of normal untreated rats.  
Diabetic Control- Severe damage to the islets of Langerhans and reduced dimensions of 
islets results damage of pancreas in alloxan-treated diabetic control rats.  
Serankottai Thiravagam 1ml/kg-The moderate damage to the islets of Langerhans and 
reduced dimensions of islets. 
Serankottai Thiravagam 2ml/kg- partial restoration of normal cellular population and 
enlarged size of β-cells with hyperplasia were seen.  
Standard-  
Restoration of normal cellular population size of islets with hyperplasia by Glibenclamide 
was seen.  
CONCLUSION 
 This study results indicates that Serankottai Thiravagam have significant anti-
hyperglycemic activities in alloxan-induced hyperglycemic rats with changes in body 
weight. Hence the above discussion reveals that Serankottai Thiravagam at high dose 
(2ml/kg) is moderately effective. The knowledge of the system of diabetes mellitus, as the 
history reveals, existed with the Indians since prehistoric age. 'Madhumeha' is a disease in 
which a patient passes sweet urine and exhibits sweetness all over the body, i.e., in sweat, 
mucus, breathe, blood, etc. In the present study, diabetic rats had lower body weights, 
high blood glucose level as compared to the normal rats.  
 Treatment with Serankottai Thiravagam not significantly enhanced the average 
body weights of rats which indicate muscle wasting resulted due to hyperglycemic 
condition. So it can be concluded that the Serankottai Thiravagam have moderate 
antidiabetic effects in alloxan-induced diabetic rats. The possible mechanism for this 
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action might be due to the inhibition of the enzyme glycogen phosphorylase, an enzyme 
that catalyzes the process of glycogenolysis. This might be the cause for depletion of 
glucose and lipid parameters such as total cholesterol and triglyceride in hyperglycemic 
condition. Thus the claim made by the traditional Indian siddha systems of medicine 
regarding the use of Serankottai Thiravagam in the treatment of diabetes stands confirms. 
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Table 1.Oral Glucose Tolerance Test 
 
 
Treatment ( dose / kg body 
weight) 
Blood glucose (mg/dl) 
Fasting 30 min 90 min 
Normal 72.4 ± 2.4 81.20 ± 2.1** 86.4 ± 2.8** 
Glucose; 2g. 72.9 ± 2.6 168.24 ± 1.8 226.04 ± 6.4 
SKT (1ml/kg)+Glucose 74.1 ± 2.5 96.20 ± 3.4** 90.12 ± 4.2** 
SKT-II (2ml/kg)+Glucose 73.6 ± 2.2 84.42 ± 2.32** 81.00 ± 2.3** 
Glibenclamide (5mg/kg) 71.5 ± 2.4 96.18 ± 4.12** 92.15 ± 6.1** 
Values are as mean ± S.E.M 
 
**P <0.01; Vs group II; n=6 
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Table.2. Measurement of Body weight changes after Serankottai Thiravagam 
treatment 
 
 
Drug 
treatment 
Periodical Weight changes 
Day0 Day1 Day2 Day4 Day8 Day14 
Normal  158.32±
2.12 
161.30±
3.00 
163.15±2.
52
b
,* 
164.88±3.4
5
a
,** 
168.22±4.1
8
a,
** 
172.70±4.1
8
a,,
** 
Diabetic 
control 
160.41±
2.16 
156.72±
2.42 
152.8±2.2
0 
148.11±2.3
3 
122.34±2.1
2 
113.40±3.2
0 
SKT -I 
1ml/kg 
158.67±
2.44 
160.12±
2.30 
158.82±2.
54 
155.28±4.6
3 
141.00±3.1
5
a,
** 
133.12±3.2
4
a,
** 
SKT -II 
2ml/kg 
159.52±
2.50 
161.40±
2.25 
157.17±3.
28 
143.20±3.4
6
a
 
133.72±3.3
7
a
 
121.10±2.3
0
a
 
Glibencla
mide 
(5mg/kg) 
158.45±
2.34 
161.76±
2.58 
164.42±2.
71* 
170.16±2.2
8** 
172.53±2.9
3** 
182.12±2.9
5** 
Values are as mean ± S.E.M 
 a
P <0.001; 
b
P <0.05 Vs Normal, **P <0.01; *P <0.05 Vs 
Diabetic Control; n=6 
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Table: 3. Fasting serum Glucose concentration is normal and Alloxan-induced 
diabetic rats 
 
Treatment  
Fasting serum Glucose concentration (mg/dl) measured at 
regular intervals 
Day 1 Day 5 Day 10 Day 14 
Normal  74.52 ±  
2.42
a,
** 
72.37  ± 
3.04
a,
** 
74.30 ± 
4.10
a,
** 
72.23±2.32
a,
** 
Diabetic control 215.72±10.14 226.14 ± 11.4 254.25  ±9.12 292.56±12.88 
SKT -I 1ml/kg 211.25 ± 
8.02
a
 
196.22 ± 12.13
a
 
182.72 ± 
10.00
a,
** 
180.21±11.32
a,
** 
SKT -II 2ml/kg 222.18 ± 
9.24
a
 
184.40 ±  
10.26
a,
* 
172.14 ± 
8.65
a,
** 
158.00±9.00
a,
** 
Glibenclamide 
(5mg/kg) 
230.62 ± 
10.11
a
 
162.12±8.21
a,
** 
158.4 ± 
9.14
a,
** 
128.65±7.16
a,
** 
Values are as mean ± S.E.M 
 a
P <0.001; 
b
P <0.05 Vs Normal, **P <0.01; *P <0.05 Vs 
Diabetic Control; n=6 
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Table: 4. Lipid profile in normal and effect of Serankottai Thiravagam in Alloxan-
induced diabetic rats. 
Values are as mean ± S.E.M; 
a
P <0.001; 
b
P<0.01; 
c
P<0.05 Vs Normal; 
d
P <0.001 Vs 
Diabetic; n=6 
 
 
 
 
 
 
 
 
 
 
 
Treatment 
 
Dose               
Parameters (mg/dl) 
Total 
Cholesterol  
Triglycerides HDL LDL 
Normal 
control 
10mg/kg 
of vehicle 
75.60±9.00 70.46±5.88 35.10±8.72 36.22±2.16 
a,**
 
Diabetic 
control 
- 82.10±8.92 74.20±10.22 27.02±2.28 138.14±5.21 
SKT –I (1ml/kg) 79.01±6.46 80.62±9.12 36.81±5.62 79.92±5.19 
a,**
 
SKT –II (2ml/kg) 72.18±5.81 74.40±6.51 34.00±3.13 68.10±5.45 
a,**
 
Glibenclamide  (5mg/kg) 84.2±6.22 72.51±7.09 40.52±10.00 34.18±5.10 
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HISTOPATHOLOGICAL IMAGES OF PANCREASE OF DIFFERENT 
GROUP 
 
DIABETIC CONTROL    NORMAL     
    
SKT – I      SKT – II 
   
 
STANDARD 
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ANNEXURE-V 
BIO –STATISTICS 
ANTIDIABETIC EFFEICACY OF SEERONKOTTAI THIRAVAGAM ON 
HUMAN SUBJECTS -A CLINICAL STUDY 
INTRODUCTION: 
 Neerizhivu (Diabetes mellitus) is the commonest endocrine disorder that affects 
more than 100 million people worldwide. It is caused by deficiency or ineffective 
production of insulin by pancreas which results in increase or decrease in concentrations 
of glucose in the blood. It is found to damage many of the body systems, particularly the 
blood vessels and nerves. The study was carried out in post-graduate’s department of 
Maruthuvam, Government Siddha Medical College attached to Aringnar Anna Hospital 
of Indian Medicine, Chennai -106. 
METHODS  
 For carrying out the study, clinical protocol was set and was approved by the 
institutional ethical committee. This study was performed under the supervision of 
physicians. Inclusion and exclusion criteria were formed for the study. Written consent 
was taken from the patients. Initial postprandial blood glucose level was estimated at the 
time of enrolment in the study and then after each week during the entire period of the 
study. At the end of the study, the initial and final readings were compared. 
Inclusion Criteria:  
 Type II diabetic patients with fasting plasma glucose level equal to or greater than 
140 mg/dl of blood without any detectable/visible complications. Type II diabetic patients 
taking oral hypoglycemic agents with history of inadequate control of blood glucose with 
these agents. The patients were of either sex (male or female) above 30 years. 
Exclusion Criteria: 
 Pregnant or nursing patients, Smokers, Patients with GIT, hepatic, cardiovascular, 
renal or endocrine disorder (other than diabetes mellitus) which can interfere with the 
absorption, metabolism and excretion of the study drug Seeronkottai Thiravagam. 
Patients with any complication of diabetes mellitus. Patients suffering from type 1 
(IDDM) diabetes mellitus. 
Subjects:  
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 The selected subjects were medically examined and given code numbers and were 
asked to present themselves on a specified date for sample collection. Initial postprandial 
blood glucose level (PPBGL) was estimated at the time of enrolment in the study and 
then after each week during the entire period of the study.  
Blood Sample:  
 Blood samples (3-5 ml) were drawn from each patient and control subject by 
vene-puncture through plastic disposable syringes. The blood samples were collected in 
clean oven dried glass bottles which were previously rinsed with 1% sodium fluoride, 3% 
potassium oxalate solution to prevent coagulation and glycolysis. The plasma was 
separated after centrifugation. Any sample showing haemolysis was discarded. After 
separation of plasma, it was transferred to clean, previously acid rinsed, washed and oven 
dried glass bottles with plastic caps. The plasma glucose estimation was done 
immediately on the same day by O-toluidine method. 
General Plan of Study:  
 Seeronkottai thiravagam dried in shadow, were powdered and its decoction was 
used for the study. A suitable dose was decided by initial randomized study in the first 
week. The study was performed in two different groups for a period of 16 weeks. Each 
group was having 20 NIDDM patients. 
Group I - In Patients received only Seeronkottai thiravagam 10 ml twice daily.  
Group II - Out Patients Seeronkottai thiravagam 10 ml received  twice daily.  
Drop Outs: No dropouts recorded in the study. 
Compliance: All participants in the study were showing the compliance and were 
following the instruction regarding the diet and exercise. 
Untoward Effects: Some of the patients they complained about the flatulence. It may be 
due to the bulking effect of FG where as some others complained about the headache 
which may be psychological. 
RESULTS 
 During this dissertation work on Neerizhivu (Diabetes Mellitus)-20 patients were 
examined as in-patients in the hospital and 20 patients in the out patients department.  
Objective parameters analysed were  
 Blood Sugar – Fasting before and after treatment. 
 Blood sugar – post prandial –Before and after treatment. 
 Assessment of HbA1c-Beore and after treatment. 
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 There were significant changes in PPBGL of group II as compared to all other 
groups. The order of decrease in PPBGL was Group II>I, whereas there were no any 
significant results seen in control patients. The statistical results are summarized in the 
Table 1 and Fig.  
 
 
 
 
 
P value and statistical significance:  
The two-tailed P value is less than 0.0001 
By conventional criteria, this difference is considered to be extremely statistically 
significant.  
 
Confidence interval: 
The mean of Group One minus Group Two equals 64.20 
95% confidence interval of this difference: From 55.03 to 73.37  
 
Intermediate values used in calculations: 
t = 14.1625 
df = 39 
standard error of difference = 4.533  
 
GROUPS MEAN SD SEM 
 
BEFORE 
TREATMENT 
 
 
169.18 
 
46.86 
 
7.41 
 
 
AFTER 
TREATMENT 
 
104.98 
 
 
25.41 
 
 
4.02 
FASTING 
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P value and statistical significance:  
 
The two-tailed P value is less than 0.0001 
By conventional criteria; this difference is considered to be extremely statistically significant.  
 
Confidence interval: 
 
The mean of Group One minus Group Two equals 97.38 
95% confidence interval of this difference: From 86.56 to 108.19  
 
Intermediate values used in calculations: 
 
t = 18.2148 
df = 39 
standard error of difference = 5.346  
 
POST PRIANDIAL 
GROUPS MEAN SD SEM 
 
BEFORE 
TREATMENT 
 
 
271.68 
51.31 
 
8.11 
 
 
 
AFTER 
TREATMENT 
 
174.30 
 
 
48.70 
 
7.70 
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P value and statistical significance:  
 
The two-tailed P value is less than 0.0001 
By conventional criteria; this difference is considered to be extremely statistically significant.  
 
Confidence interval: 
 
The mean of Group One minus Group Two equals 3.075 
95% confidence interval of this difference: From 2.501 to 3.649  
 
Intermediate values used in calculations: 
 
t = 11.2052 
df = 19 
standard error of difference = 0.274  
 
 
 
 
Hb A1c 
GROUPS MEAN SD SEM 
 
 
 
BEFORE 
TREATMENT 
 
 
 
10.020 
 
 
 
1.348 
 
 
0.301 
 
 
AFTER 
TREATMENT 
 
6.945 
 
 
 
0.938 
 
 
0.210 
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ANNEXURE-V 
CONSENT FORM 
                       I certify I have disclosed all the details about the study in the terms readily 
understood by the patient. 
 
DATE:                                                                                       SIGNATURE 
                                                                                                  NAME 
CONCENT BY THE PATIENT 
             I have been informed to my satisfaction by the attending physician the purpose of the 
clinical trial and the nature of the drug treatment and follow up including the lab investigation 
to be performed to monitor and safeguard my body functions. 
                    I am aware of my right to opt out of the trial at any time during the course of the 
trial without having to give reasons for doing so. 
                  I exercising my free power of choice, hereby give my consent to be included as a 
subject in the clinical trial of SERRONKOTTAI THIRAVAGAM for the treatment of 
NEERIZHIVU. 
 
 
DATE:                                                                                                        SIGNATURE 
 
                                                                                                                        NAME 
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CASE SHEET  
POST GRADUATE DEPARTMENT - BRANCH-I 
 (POTHU) MARUTHUVAM  
GOVT. SIDDHA MEDICAL COLLEGE & ANNA HOSPITAL, CHENNAI-106. 
CASE SHEET PROFORMA FOR “NEERIZHIVU” 
 
WARD NO. : NATIONALITY : 
I.P. NO : RELIGION : 
BED NO : OCCUPATION : 
NAME : INCOME : 
AGE :   
SEX : DOA : 
PERMANENT ADDRESS  : 
  DOD : 
 
  DIAGNOSIS : 
TEMPORARY ADDRESS:                                      
                                                                                   MEDICAL OFFICER       : 
 
 
 
COMPLAINTS AND DURATION: 
 
 
 
 
 
 
HISTORY OF PRESENT ILLNESS: 
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HISTORY OF PAST ILLNESS: 
 
 
 
 
PERSONAL HISTORY & HABITS: 
 
                        FOOD :               VEG            NON-VEG 
 
 MARRITAL STATUS :         SINGLE            MARRIED 
 
 
 
FAMILY HISTORY                                          
 
 
GENERAL  EXAMINATION: 
1. Body built                : 
2. Consciousness         : 
3. Nourishment             : 
4. Decubitus                 : 
5. Anaemia                   : 
6. Jaundice                   :  
7. Cyanosis                  : 
8. Clubbing                   : 
9. Lymphadenopathy   : 
10. Oedema                   :          
11. Jugular venous pulsations: 
12. Enlarged vein           : 
13. Miscellaneous           : 
 
VITAL SIGNS: 
14. Pulse rate            : 
15. Temperature        : 
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16. Respiratory rate   :  
17. Heart  Rate          : 
18. Blood Pressure.   : 
 
SIDDHA ASPECTS: 
NILAM (PLACES): 
1. Kurinchi (Moutains and their adjoining Areas)   : 
2. Mullai (Forest and their adjoining Areas)            : 
3. Marudham (Fertile  and their adjoining  Areas)   : 
4. Neithal (Sea and their adjoining Areas)               : 
5. Paalai (Desert and their adjoining Areas)             : 
PARUVA  KAALAM (SEASONS) : 
1. Kaar Kaalam (Aavani-Puratasi) Aug-sept.           : 
2. Koothir Kaalam (Iypasi-Karthigai) Oct-Nov.       : 
3. Munpani Kaalam (Maargazhi-Thai) Dec-Jan.     : 
4. Elavenil Kaalam (Chithirai-Vaikasi) Apr-May     :  
5. Mudhuvenil  Kaalam (Aani-Aadi) Jun-Jul          : 
YAAKAI (UDAL) : 
1. Vali udal          : 
2. Azhal udal       : 
3. Iyya Udal         : 
4. Kalappu Udal  : 
GUNAM : 
1. Sathuva Gunam : 
2. Rajo Gunam       : 
3. Thamo Gunam   : 
IYAMPORIGAL  (SENSORY ORGANS):  
1. Mei  - Unarthal        : 
2. Vaai  - Suvaiththal  : 
3. Kan  - Parththal      : 
4. Mooku –Mugarthal : 
5. Sevi – Kettal           : 
KANMENTHIRIYAM / KANMAVIDAYAM: 
1. Kai   -  Koduththal                : 
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2. Kaal  - Nadaththal                :       
3. Vaai  - Pesal                         : 
4. Eruvai -  Malam Kazhithal    : 
5. Karuvai – Aananthithal         : 
 
PIRA URUPUKALIN NILAI: 
1. Irudhayam        : 
2. Puppusam        : 
3. Eraippai            : 
4. Kalleral             : 
5. Manneeral        : 
6. Kudal                : 
7. Siruneeragam   : 
8. Karuppai           : 
9. Moolai               : 
 
UYIR THATHUKKAL: 
 Vatham: 
1. Pranan             : 
2. Abanan            :    
3. Viyanan            : 
4. Udhanan          : 
5. Samanan         : 
6. Naagan            : 
7. Koorman          : 
8. Kirukaran         : 
9. Devadathan     : 
10. Thanenjeyan    : 
PITHAM: 
1. Anal Pitham           : 
2. Ranjaga Pitham      : 
3. Saadhaga Pitham   : 
4. Aalosaga Pitham    : 
5. Prasaga Pitham     : 
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KAPHAM: 
1. Avalambagam : 
2. Kledagam        : 
3. Podhagam       : 
4. Tharpagam      : 
5. Santhigam       : 
 
UDAL THATHUKKAL: 
1. Saaram        : 
2. Senneer       : 
3. Oon              : 
4. Kozhuppu     : 
5. Enbu            : 
6. Moolai          : 
7. Sukkilam / Suronitham: 
Envagai Thervu: 
1. Naa - Niram     - 
  Thanmai - 
  Pulan      -  
2. Niram              - 
3. Mozhi -  
4. Vizhi -  
5. Sparisam         - 
6. Malam - Niram- 
 Erugal  / Elagal- 
 Manam- 
 Nurai- 
 
7.  Moothiram        a. Neerkuri:- a) Niram- 
                                                                                   b) Manam- 
                                       c) Edai- 
                                       d) Nurai- 
                                       c) Enjal- 
                      b. Neikuri:- 
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 8. Naadi - Thani Naadi      - 
    Kalappu Naadi  - 
    Mukkutra Naadi - 
    Thondha Naadi  - 
 
MODERN ASPECTS: 
1. Cardio Vascular System: 
2. Respiratory system        :   
3. Central Nervous System: 
4. Genito-Urinary System   : 
5. Gastro intestinal Tract    :  
Laboratory Investigation: 
I. Blood : TC - 
       DC- 
  ESR-  
  Hb %- 
  Group- 
  Urea- 
  Creatinine- 
  Cholesterol- 
  VDRL- 
  Sputum for AFB- 
  Mantoux test- 
  Sugar  - Random- 
     Fasting- 
     Post Prandial- 
  Glycosylated Haemoglobin (HbAIC)- 
  GTT    - 
2.   Urine : 
     Albumin: 
     Sugar   : 
         Deposits: 
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3. Motion:         
   Ova- 
              Cyst- 
4. X-ray Chest : PA View 
5.  ECG : 
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CASE SUMMARY 
FINAL DIAGNOSIS:  
MEDICINE: 
                 1. SEERANKOTTAI THIRAVAGAM-10drops/Bd With water 
MEDICAL ADVICE: 
Pathiam(Do’s and Dont’s): 
PROGNOSIS CHART: 
Signs and Symptoms: 
S.No. 
CLINICAL 
FEATURES 
BEFORE 
TREATMENT 
DURING 
TREATMENT 
AFTER 
TREATMENT 
 
 
24days 48days  
1. Polyurea     
2. Polyphagia     
3. Polydipsia     
4. Balanitis / Pruritis vulva     
5. Itching all over body     
6. Pain all over body     
7. 
Dryness of the mouth 
and throat 
    
8. Constipation     
9. Skin infection     
10. Emaciation     
11. Dry skin     
12. Peripheral  Neuritis     
13. Ulcer in the foot     
14. Diabetic cataract     
 
Medical officer                                                 
                                                                                                                                HOD                                                 
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DISCHARGE CASE SHEET 
POST GRADUATE DEPARTMENT, MARUTHUVAM (BRANCH-I) 
GOVT. SIDDHA MEDICAL COLLEGE & HOSPITAL, CHENNAI-106. 
“NEERIZHIVU” 
 
IP No : OCCUPATION : 
WARD NO : INCOME : 
BED NO : NATIONALITY : 
NAME : RELIGION : 
AGE : DOA                                :  
SEX : 
ADDRESS : DOD                                : 
  TOTAL NO. OF 
  DAYS TREATED : 
  RESULT                          : 
                                                                                   DIAGNOSIS : 
  MEDICAL OFFICER       :  
 
 
S.No. CLINICAL FEATURES 
DURING  
ADMISSION 
DURING 
DISCHARGE 
1. Polyurea   
2. Polyphagia   
3. Palydipsia   
4. Balanitis / Pruritis vulva   
5. Itching all over body   
6. Pain all over body   
7. Dryness of the mouth and throat   
8. Constipation   
9. Skin infection   
10. Emaciation   
11. Dry skin   
12. Peripheral  Neuritis   
13. Ulcer in the foot   
14. Diabetic cataract   
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